Session 51 1 4 1 Conference Hall 1–3 Sunday, June 22, 2008

Transcription

CME
13th International Congress on Infectious Diseases
Session 51
Conference Hall 1–3
Kuala Lumpur Convention Centre (KLCC)
Sunday, June 22, 2008
09:00–09:45
Plenary
PLENARY LECTURE V
Chair:
Jingoro Shimada,Tokyo, Japan
51.001
The Role of Neutrophils in Infection
W. Nauseef
Iowa City, IA (USA)
Final Program
141
Friday, June 20 2008
12:30 - 14:15
Kuala Lumpur Convention Centre
Plenary Theatre
Join our symposium
Life-threatening Infections in
Immuncompromised Patients
Presenters:
Dr Christopher Lee, Malaysia
Professor Thomas Patterson, USA
Dr Monica Slavin, Australia
Visit our Pﬁzer booth at the
13 International Congress on Infectious Disease,
June 19-22, 2008.
th
CME
Session 52
Conference Hall 2
10:15–12:15
Symposium
COMMUNITY-ACQUIRED MRSA: WHAT IN THE WORLD IS GOING ON?
Co-Chairs:
Henry Chambers, San Francisco, CA, USA
Wing-Hong Seto, Hong Kong, China
52.001
The Origin and Evolution of MRSA
B. Kreiswirth
New Jersey, NJ (USA)
52.002
Evasion of Innate Host Defense by Staphylococcus aureus
F DeLeo
Hamilton, MT (USA)
52.003
Microbial Pathogenesis of Community-Acquired MRSA Infections
T.J. Foster
Dublin (Ireland)
52.004
Clinical Aspects of the Community-Acquired MRSA Epidemic
H. Chambers
San Francisco, CA (USA)
supported in part by a grant from
Pfizer
Final Program
143
CME
Session 53
Plenary Theatre
10:15–12:15
Symposium
PARTNERING IN R&D TO DEVELOP NEW DRUGS
FOR THE MOST NEGLECTED DISEASES
Co-Chairs:
Tan Sri Datuk Dr. Mohd Ismail Merican, Putrajaya, Malaysia
Visweswaran Navaratnam, Penang, Malaysia
53.001
Current Discovery Research and Most Promising Avenues, Including
Anti-Trypanosomal Screens of Kitasato Natural Productss
H.Yamada
Tokyo (Japan)
53.002
Progress in Discovery and Development of Drug to Treat Dengue Fever
P. Herrling
Basel (Switzerland)
53.003
Improving Malaria Treatment and Compliance–Examining Clinical Evidence on a
New Fixed-Dose Combination of Artesunate and Mefloquine
E. Ashley
Mae Sot,Tak (Thailand)
53.004
Efficacy and Safety of Artesunate-Amodiaquine Fixed-Dose Combination in India
N.Valecha
Delhi (India)
53.005
New Treatment Options for Visceral Leishmaniasis: What’s Available and in Clinical
Development
P. Olliaro
Geneva (Switzerland)
supported by an educational grant from the
DRUGS FOR NEGLECTED DISEASES initiative (DNDi)
1 4 4 Final Program
CME
Session 54
Banquet Hall
10:15–12:15
Symposium
EXTENSIVELY DRUG-RESISTANT TB: NEW NAME OR NEW PROBLEM
Co-Chairs:
Timothy Brewer, Montreal, Canada
Eduardo Gotuzzo, Lima, Peru
54.001
The Epidemiology of XDR TB in KwaZulu Natal South Africa:
A New name or a New Problem
R. Rustomjee, A. Pym
Durban (South Africa)
54.002
MDR-TB and XDR-TB in Asia
T.E. Tupasi
Makati, Metro Manila (Philippines)
54.003
Rapid Diagnosis of MDR-TB in Low-Resource Settings
D.A.J. Moore
London (United Kingdom)
54.004
The Epidemiology of MDR-TB in Peru
E. Gotuzzo
Lima (Peru)
organized in collaboration with the
International Society of Chemotherapy (ISC)
Final Program
145
CME
Session 55
Room 304/305
10:15–12:15
Symposium
CONTROLLING JAPANESE ENCEPHALITIS:
ADVANCES IN DETECTION AND PREVENTION
Co-Chairs:
Supamit Chunsuttiwat, Nonthaburi,Thailand
John Wecker, Seattle,WA, USA
55.001
Measuring Japanese Encephalitis Disease Burden: Challenges in Surveillance
and Diagnostics
M. Fischer, S. Hills, E. Staples, B. Johnson, M.Yaich,T. Solomon
Fort Collins, CO, Seattle,WA (USA), Liverpool (United Kingdom)
55.002
Japanese Encephalitis in Indonesia: New Findings on Geographical Extent
and Disability from the Disease
E.R. Sedyaningsih, S. Ompusunggu, S. Hills, N.K. Susilarini,V. Moniaga, A. Sasmito,
D.Yuwono, G.Wahyuhono, M. Sembiring Maha, A. Suwandono
Jakarta (Indonesia), Seattle (USA)
55.003
The Landscape of New Vaccines for Japanese Encephalitis: Country-Level Strategies
for Introduction
M.R.N. Abeysinghe, P.R.Wijesinghe
Colombo (Sri Lanka)
55.004
Japanese Encephalitis Control:What Can Be Achieved?
J. Hombach
supported by an educational grant from
PATH
1 4 6 Final Program
CME
Session 56
Room 302/303
10:15–12:15
Symposium
INTERNATIONAL PERSPECTIVES ON PALLIATIVE CARE
FOR PEOPLE WITH HIV/AIDS
Co-Chairs:
David Casarett, Philadelphia, PA, USA
Guillermo Acuña, Santiago, Chile
56.001
International Perspectives on Hospice and Palliative Care for HIV/AIDS
S.R. Connor
Alexandria,VA (USA)
56.002
Clinical Issues in Palliative Care for HIV/AIDS
E. Hamzah
Kuala Lumpur (Malaysia)
56.003
Successful Development in Hospice and Palliative Care in Asia
C.R. Goh
Singapore (Singapore)
56.004
National and International Measurement Opportunities
D. Casarett, S. Connor
Philadelphia, PA, Alexandria,VA (USA)
Final Program
147
CME
Session 57
Room 301
10:15–12:15
Oral Presentations
HOT TOPICS
Co-Chairs:
Larry Madoff, Brookline, MA, USA
Adeeba Kamarulzaman, Kuala Lumpur, Malaysia
57.001
Role of the C-terminal Domain of OmpA Receptor, Ecgp in Stat3 Interaction
During Escherichia coli K1 Invasion of Brain Microvascular Endothelial Cells
R. Maruvada, P. Nemani
Los Angeles, CA (USA)
57.002
Molecular Epidemiology of H5N1 Avian Influenza Virus: Correlations between
Antigenic Drift, Geographical Migration and Expansion of Viral Diversity
T.Y. Lam, O.G. Pybus, C.C. Hon, F.C. Leung
Hong Kong (China), Oxford (United Kingdom)
57.003
Pathogenicity of Lagos Bat Virus—An African Rabies-Related Lyssavirus
W. Markotter, I. Kuzmin, C.E. Rupprecht, L.H. Nel
Pretoria (South Africa), Atlanta, GA (USA)
57.004
Design and Development of a Novel Electrochemical DNA Biosensor for Rapid
Molecular Identification of Enterococcus faecium
Y.Y. Chan, K. Balqis, A.O. Dilsat, S.Y. Lee, P. Lalitha , M. Ozsoz, M. Ravichandran
Kubang Kerian (Malaysia), Izmir (Turkey)
57.005
Development of a Thermostabilized Cholera-NASBA-ELISA Assay for the
Specific Detection of Vibrio cholerae
S.Y. Lee,Y.Y. Chan, H.T. Elina, M. Ravichandran, F.Z. Zainul, P. Lalitha
Kubang Kerian (Malaysia)
57.006
Epidemiology and Pathogenicity of Methicillin-Resistant Staphylococcus aureus
Isolates from Pediatric Patients in China
W.S. Zhang, X.Z. Shen, H. Zhang, C.Q.Wang, J.H. Zhen, Q.L. Deng, L. Liu,
X.H.Wang,Y.H.Yang
Beijing, Chongqing, Guangzhou, Shanghai (China)
57.007
Sero-Epidemiological Results in the Human Population Exposed to Highly
Pathogenic Avian Influenza H5N1 Outbreak in a Large Poultry Farm in the
East of England
B. Rodrigues, S. Bracebridge, M. Zambon, N.Verlander, N. Coetzee,T. Sundkvist,
K. Hoschler, I. Roddick, J. Kearney, P. Nair
London (United Kingdom)
57.008
Paediatric Community-Associated Methicillin-Resistant Staphylococcus aureus
Infection at Chris Hani Baragwanath Hospital, Soweto, South Africa
M.J. Groome, M.J. Kohler,W. Albrich, M. Khoosal, S.A. Madhi
Johannesburg (South Africa)
57.009
Retrospective Investigation of a Dengue-Like Syndrome in a Rural Area
in Western Cameroon
M. Demanou, C. Antonio-Nkondjio, E. Ngapana, E. Kouagang, C. Nfor,
V. Ndiforchu, L.S.Vola, P.Tchendjou, D. Rousset, J.C. Manuguerra, H. Zeller
Bamenda, Kumbo,Yaounde,YAOUNDE (Cameroon), Lyon, Paris (France)
1 4 8 Final Program
CME
Session 58
Conference Hall 1–3
14:30–15:15
Plenary
PLENARY LECTURE VI
Chair:
Christopher Lee, Kuala Lumpur, Malaysia
58.001
Emerging Infections:What Have We Learned After 15 Years?
D. Heymann
Final Program
149
CME
Session 59
Conference Hall 2
15:45–17:45
Symposium
TREATMENT OF ACUTE OTITIS MEDIA IN CHILDREN—NEVER SIMPLE
Ron Dagan, Beer-Sheva, Israel
Adriano Arguedas, San Jose, Costa Rica
59.001
How to Evaluate Response to Treatment in AOM
D.P. McCormick
Galveston, TX (USA)
59.002
Summary of Studies With New Antibiotics in AOM in Last Decade—Where Are We?
A. Arguedas
San Jose (Costa Rica)
59.003
What Do Antibiotics Really Do In AOM?
R. Dagan
Beer-Sheva (Israel)
59.004
Delayed Antibiotic Treatment of AOM—Risks and Benefits
P. Little
Southampton (United Kingdom)
Co-Chairs:
1 5 0 Final Program
CME
Session 60
Banquet Hall
15:45–17:45
Symposium
TREATMENT OF INFECTIONS CAUSED BY HIGHLY
DRUG-RESISTANT BACTERIA
Co-Chairs:
Chen-Yi Liu,Taipei, Taiwan
Victor Lim, Kuala Lumpur, Malaysia
60.001
Multi-Resistant Enterobacteriaceae
J. Turnidge
North Adelaide (Australia)
60.002
Carbapenem-Resistant Pseudomonas and Acinetobacter
A. Kamarulzaman
60.003
Ceftriaxone-Resistant Salmonella
A. Gupta
Baltimore, MD (USA)
60.004
Fluroquinolone-Resistant Gonorrhea
P.R. Hsueh
Taipei (Taiwan)
Infectious Disease Society of Taiwan (IDST) and Western Pacific Society of Chemotherapy (WPSC)
Final Program
151
CME
Session 61
Room 304/305
15:45–17:45
Symposium
UPDATE ON CLINICALLY SIGNIFICANT ANAEROBES
Co-Chairs:
Carl-Erik Nord, Stockholm, Sweden
Visanu Thamlikitkul, Bangkok,Thailand
61.001
Antimicrobial Resistance Among Anaerobes—The European Experience
C.E. Nord
Stockholm (Sweden)
61.002
Clostridium difficile Type O27, Coping with a More Virulent Strain
E.J. Kuijper, R.Vonberg, M.Wilcox, P. Gastmeier
Leiden (Netherlands), Berlin, Hannover (Germany), Leeds (United Kingdom)
61.003
Molecular Biology of Protein Glycosylation in the Symbiotic Anaerobe
Bacteroides Fragilis
C.M. Fletcher, M.J. Coyne, O.F.Villa, S. Park, P. Azadi, L.E. Comstock
Boston, MA, Athens, GA, New York, NY (USA)
61.004
Anaerobes As Biofilms
G. Donelli, E. Guaglianone, R. Cardines, P. Mastrantonio
Rome (Italy)
International Society for Anaerobic Bacteria (ISAB)
1 5 2 Final Program
CME
Session 62
Room 302/303
15:45–17:45
Symposium
ANTIRETROVIRALS FOR PREVENTION OF HIV
Co-Chairs:
Kenneth Mayer, Providence, RI, USA
Norliza Ariffin, Kuala Lumpur, Malaysia
62.001
Can Expanded Treatment Slow the AIDS Epidemic? The Public Health Perspective
N. Kumarasamy
Chennai (India)
62.002
Can Expanded Treatment Slow the AIDS Epidemic? The Behavioral Scientist's View
K. Chillag
Atlanta, GA (USA)
62.003
Antivirals in Uninfected People: PrEP and PEP
A.E. Grulich
Sydney (Australia)
62.004
Antivirals for HIV Prevention
K. Mayer
Providence, RI (USA)
Final Program
153
CME
Session 63
Room 301
15:45–17:45
Symposium
EMERGING RICKETTSIOSES IN ASIA
Didier Raoult, Marseilles, France
Jaime Torres, Caracas,Venezuela
63.001
Spotted Group Rickettsioses in Asia
O. Mediannikov, I.Tarasevich
Moscow (Russia)
63.002
Scrub Typhus
Y. Suputtamongkol
Bangkok (Thailand)
63.003
Different Clinical Expression of Murine Typhus and Scrub Typhus
P.N. Newton
Vientiane (Lao People's Democratic Republic)
63.004
Diagnosis of Rickettsioses
D. Raoult
Marseilles (France)
Co-Chairs:
1 5 4 Final Program
Session 64
Ballroom (Exhibition Area ~ Level 3)
12:30–13:30
Poster Presentations
INFECTION CONTROL AND NOSOCOMIAL INFECTIONS
Hospital Contamination with Resistant Pseudomonas aeruginosa
A. Ahani-Azari, A. Danesh
Gorgan (Iran)
64.002
Biofilm Production and Molecular Epidemiology of P.aeruginosa by RAPD Isolated
from Intravascular Catheters in Tertiary Care Hospital
A.S. Rao, C.V. Raghuveer, I. Karunasagar
Mangalore, Manipal (India)
64.003
Infectious Complications after Renal Allotransplantation: Differentiatative Diagnosis
with Rejection Crisis and Possibilities for Prediction by Immunologic Monitoring
P. Lazarova, K. Metodiev, A. Kisselova
Sofia,Varna (Bulgaria)
64.004
Administration of Preoperative Oral Antibiotics is a Risk Factor for Postoperative
MRSA Enterocolitis
Y.Yoshida, S. Kusachi,Y. Arima, H.Tanaka,Y.O. Nakamura, R.Watanabe,T. Saito,
J. Sato, J. Nagao,Y. Saida,Y. Okamoto, M.Watanabe
Meguro (Japan)
64.005
Nosocomial Bacterial Infections and Their Antimicrobial Resistance Patterns in
University Hospitals of Hamadan, Iran
S. JamalOmidi, S.H. Hashemi, M. Mamani, F. Keramat, A. Niayesh, S. Rahimi
Hamedan (Iran)
64.006
Effective Intervention and Vaccination Strategies Against Nosocomial Infection Based
on Network Analysis
T. Ueno, N. Masuda
Tokyo (Japan)
64.007
Health Care Worker Immune Status and Risk Perception of Acquisition of
Vaccine Preventable Diseases
M.I.S. Dinelli, T.N.F. Moreira, E.R.C. Paulino, M.C.P. Rocha, F.B. Graciani, M.I. de
Moraes-Pinto
São Paulo (Brazil)
64.008
Health Care Workers Occupational Accidents in a Brazilian Hospital
T.N.F. Moreira, M.I.S. Dinelli, E.R.C. Paulino, M.C.P. Rocha, F.B. Graciani, M.I. de
Moraes-Pinto
São Paulo (Brazil)
64.009
Underreporting of Occupational Exposures to Sharp Injuries
Z. Hassan
Zarqa (Jordan)
Final Program
155
64.001
Session 64
12:30–13:30
64.010
Clinical, Microbiological, and Epidemiologic Characteristics of Acinetobacter
Infections in a University Hospital,Tehran, Iran
M. Barati, S. Noorbakhsh, M.Talebi-Taher, R. Abasi
Tehran (Iran)
64.011
Pretreatment of Catheter with Biosurfactant for Inhibiting Biofilm Formation
Z.P. Bhathena, A.D. Mule
Mumbai (India)
64.012
What is the Role of Stethoscope in Transmitting Infection at a
Tertiary Care Saudi Center?
A. Alothman, A. Bukhari, H. Maimony, S. Al Johani, A. Muhanna
Riyadh (Saudi Arabia)
64.013
Four Years Surveillance of Antimicrobial Susceptibility in Pseudomonas aeruginosa
Nosocomial Isolates from a Central Hospital in Portugal
O. Cardoso, A.F. Alves, R.M. Leitão
Coimbra (Portugal)
64.014
Changes in the Incidence of Central Venous Catheter Related Infection in
Surgical Patients Receiving Total Parenteral Nutrition
J. Kotsikoris, A. Zygomalas, M. Souchlakis, P.Terzakis, M. Manousi, V. Alivizatos
Patra (Greece)
64.015
Level of Knowledge Consciousness, and Practical Knowledge of Hospital
Infection Among Health Care Providers at a Long-Term Care Facility
Y.Yoshida,Y. Kumagai,Y. Kumagai, K. Shikoshi,T. Dazai
Tokyo (Japan)
64.016
Perioperative Risk Factors for Chest Surgical Site and Leg Infections After
Cardiac Surgery
Z. Hassan
Zarqa (Jordan)
64.017
Transmission and Control of MRSA Infection in Dermatology Indoor Patients
B. Mehta, M. Dhingra, S. Amladi, C. Nayak, S. Savant
Mumbai (India)
64.018
Uropathogen Resistance to Aminoglycosides in a Regional Hospital in Greece
T. Chimonas, F. Rozi, P. Papageorgiou, E. Chounta, M. Pavlaki, M.Vossou
Argos (Greece)
64.019
Risk Factors and Outcome for Nosocomial Infections in Pediatric Cardiac Surgery
Y.F. Huang, P.Y. Liu, C.W.Tang, K.S. Hsieh,Y.C. Liu, J.Y. Pan
Kaohsiung (Taiwan)
1 5 6 Final Program
Session 64
12:30–13:30
Clinicoetiological Study of Nosocomial Sepsis in Dermatology Ward
D.P. Asati,V.K. Sharma, S. Khandpur, G.C. Khilnani, A. Kapil
New Delhi (India)
64.021
Knowledge and Performance of the Universal Precautions Among Yemeni Nurses
A.A.K. Thabet, A. Abdulrab, S. Awdhaly, F. Amrani, N. Al-Jaber
Thamar (Yemen)
64.022
Estimation of Occupational Exposure to Blood and Body Fluid Among
Healthcare Trainees
K. Lionel, J. John, J. Muliyil
Vellore (India)
64.023
Detection and Characterization of Metallo Beta-Lactamases in Clinical Isolates of
Pseudomonas aeruginosa from Different Hospitals in Delhi, India
S.P. Singh, M. Shariff, S.S.Thukral
Delhi (India)
64.024
What does it take for a Doctor to Wash?
J.B. Suchitra, N. Lakshimidevi
Bangalore, Misore (India)
64.025
Cost and Infection Control Implications of Inappropriate Urine Bacterial Cultures
M. Hamadeh, K. Obeid, A. Khan, M. Kaabi, R. Hashmey
Al Ain (United Arab Emirates)
64.026
Molecular and Phenotypic Characterization of Metallo-Betalactamases Producing
Bacteria in a Tertiary Care Hospital
H.T. Samarasekara, J. Branley, B. Roy, M. Leroi
Sydney (Australia), Kaduwela (Sri Lanka)
64.027
Enterococcus Infections: Epidemiology, Mortality and Risk Factors in a Regional
Hospital in Greece
P. Papageorgiou,T. Chimonas, K. Mitrakou, M.Vossou, F. Rozi
Argos (Greece)
64.028
Catheter Related Blood Stream Infection—Affecting Factors
E. Kasal, P. Pelnar,T. Bergerova, I. Chytra, J. Benes, H.Vanousova
Plzen (Czech Republic)
64.029
Five Cases of Nosocomial Antibiotic-Associated Diarrhea Due to MRSA
(Methicillin-Resistant Staphylococcus aureus) at a VA Hospital in the USA
T.S. Lo, S.M. Borchardt
Fargo, ND (USA)
Final Program
64.020
157
Session 64
12:30–13:30
64.030
Handwashing Behaviors in Rural Bangladesh
A.K. Halder, S.P. Luby, A. Bhuiya, C.Tronchet, S. Akhter, R. Johnston
Dhaka (Bangladesh)
64.031
Antibiotic Prophylaxis for Complex Spinal Surgery: Impact of a Protocol Change
at a Children's Hospital
K. Tash, S. Chewning, C. Somboonwit, J. Sinnott
Tampa, FL, Boston, MA (USA)
64.032
Prevalence and Resistance Patterns of Gram-Negative Nosocomial Pathogens in an
Adult Intensive Care Unit in Malaysia
M. Mansor, G.S.Y. Ong, S. Shamala Devi, M.Y. Mohd Yasim, N. Parasakthi
Bandar Sunway, Kuala Lumpur (Malaysia)
64.033
Epidemiology of Enterobacteriaceae With Reduced Susceptibility to Third-Generation
Cephalosporins Isolated From Stool Screening at Entry to a Tertiary Care Hospital
J. Chan, D. Lye,Y.S. Leo,T.H. Koh,W.Y.Tang, A. Singh, P. Krishnan
64.034
Can We Prevent Surgical Site Infections During Cardiac Surgery by Additional Use
of a Microbial Sealant?
P.M. Dohmen, D. Gabbieri, J. Linneweber, A.Weymann,W.F. Konertz
Berlin (Germany)
64.035
Many Viruses Are Present in Infants During Winter—Impact for Isolation Procedures
H.A. Nielsen, L.P. Nielsen
Copenhagen (Denmark)
64.036
Epidemiology of Vancomycin Resistant Enterococcus (VRE) in a Singapore
Tertiary Hospital
R. Sridhar, C. Ong, S.Q.Toh, K.T. Goh, R. Lin,T.M. Ng, D.A. Fisher, P.A.Tambyah
64.037
Daily Management of Antimicrobial Prescribing Leading to Reduction of
Clostridium difficile Infections in Elderly Patients
W. Al-Wali, M. Asensio, C. Hughes, S. Ahuja
Rotherham (United Kingdom)
64.038
Journey of Infection Control in a Tertiary Care Hospital
R. Adhikary, K.R. Kulkarni, B.N. Gokul, M. Chakravarthy
Bangalore (India)
64.039
Impact of Ventilation System Design on Airborne Infectious Disease Control in an
Emergency Room
J. Chang, P. Harght
Lawrence, KS (USA)
1 5 8 Final Program
Session 64
12:30–13:30
Follow Up for Nosocomial Infections (NI) in 1200 Post Surgery Patients
at a Teaching Hospital in Guatemala
I. Cazali, J. Passarelli, J. Maldonado, J. de Leon
Guatemala (Guatemala)
64.041
Transmission of Vancomycin Resistance E. faecium Between Patients and the
Environment in Iran
M. Talebi, M.R. Pourshafie, S.S. Eshraghi
Tehran (Iran)
64.042
Occurence of Extended-Spectrum Beta-lactamases in Gramnegative Bacteria
Isolated From Hospitalised Patients in Period 2005–2006
L. Siegfried, J. Gajdosova, E. Sinajova, M. Marcin, M. Molokacova, K. Curova,
M. Sabol, M. Kmetova
Kosice,, Kosice, Michalovce, Presov, (Slovakia)
64.043
Bloodstream Infections (BSI) in the Pediatric Oncology Unit at
C.H.Baragwanath Hospital
M. Khoosal, J.Wadula, L.Wainwright, G. Naidu
Johannesburg (South Africa)
64.044
The Role of Infectious Disease Specialist (ID) in Antibiotic Policy in Hospital
B. Beovic, S. Kreft, K. Seme, M. Cizman
Ljubljana (Slovenia)
64.045
Pseudo-Outbreak of Rhizobium radiobacter Resulting From Contaminated
Diluting Saline
L. Pereira, D. Chan,T.M. Ng, R. Lin, D.A. Fisher, P.A.Tambyah
64.046
Microbiology of Bacteremia among Patients in an Intensive Care Unit of a
Tertiary Care Hospital in South India
S.S. Rajkumar, S. Kamesh, S. Padma, M. Mallika
Chennai (India)
64.047
Cats and Cockroaches from Premises of a Hospital as Pathogen-Loaded Bullets
for Nosocomial Infections
T. Ijaz, M.A. Khan, M.K. Shahzad, M.A. Muneer, M. Imran, R. Hussain
Lahore (Pakistan)
64.048
Etiological Agents of Nosocomial Infections Isolated from Hospital Staff of a
Tertiary Care Public Hospital
T. Ijaz, A.M. Akhtar, A.R. Khawaja, N. Ijaz, M. Imran, M.K. Shahzad
Lahore (Pakistan)
Final Program
64.040
159
Session 64
12:30–13:30
64.049
Isolation of Etiological Agents of Nosocomial Infections from a Hospital Environment
and Iatrogenic Spread of These Infections
T. Ijaz, F.A. Ranjha, A.R. Khawaja, M.A. Akhtar, M.A. Muneer, M.K. Shahzad
Lahore (Pakistan)
64.050
Rubbing It in: A Time-Effective Hand Hygiene Protocol for Daily Hospital Practice
A. Chow, B.F. Poh, C.Wu, J. Chan, P. Krishnan,Y.S. Leo, B. Ang
64.051
Methicillin-Resistant Staphylococcus aureus (MRSA) Detection at Admission and
During Hospitalization at the Brussels Burn Centre
D. De Vos, P. Bosmans, P. Persoons,T. Pieters, S. Jennes, J.P. Pirnay
Brussels (Belgium)
64.052
Surveillance of Multidrug Resistant Organisms (MDRO) in a Tertiary Care
Centre in Chennai, India
P. Srikanth, A. Ramesh,V. Kamat, A. Kumar, A. Manoharan, D. Mathai
Chennai,Vellore (India)
64.053
The Mobile Phone in a Tropical Setting - Emerging Threat for Infection Control
P. Srikanth, R. Ezhil, S. Suchitra, I. Anandhi, U. Maheswari, J. Kalyani
Chennai (India), Singapore (Singapore)
64.054
Nurses Are Facing the Threat of Infection from Blood Borne Pathogens Due
to Needle Prick Injuries (NPI) During Patient Care
L.I. Zungu
Pretoria (South Africa)
64.055
Gender Trend of Septicaemic Deaths in University Teaching Hospital in Kelantan
C.Y Ruhana, A. Sarimah, N.N. Naing, M.N.S. Suraiya
Kota Bharu (Malaysia)
64.056
The Etiology of Hospital-Related Central Vascular Catheter Infections.
A Prospective Microbiological Study
A. Nanetti, R. Manfredi
Bologna (Italy)
64.057
Prospective Monitoring of in Vitro Antimicrobial Susceptibility Testing of Major
Pathogens at a Large Tertiary Care Metropolitan Hospital. A Guidance for Both
Therapeutic and Prophylactic Choices
Bologna (Italy)
64.058
Commensals of Mucous Surfaces Used to Control Nosocomial Diseases:
Efficacy and Possible Acting Mechanisms
N. Boyko, J. Szabo, H. Koval, A. Kulja, K. Kritsky, I. Kalapos, E. Rajnavolgyi
Debrecen (Hungary), Uzhhorod (Ukraine), Philadelphia, PA (USA)
1 6 0 Final Program
Session 64
12:30–13:30
Role of Patients' Attendants in Transmission and Prevention of Nosocomial Infections
in Bangladeshi Public Hospitals
R. Sultana, N.A. Rimi, M.S. Islam, N. Nahar, S.P. Luby, E.S. Gurley
Dhaka (Bangladesh)
64.060
Surveillance of Nosocomial Infections at a Saudi Arabian Military Hospital for a
One-Year Period
M. Abdel-Fattah
Taif (Saudi Arabia)
64.061
An Outbreak of Pseudobacteremia Due to Burkholderia Cepacia in the Emergency
Room of a Tertiary Hospital in Trinidad & Tobago
P.E. Akpaka,W.H. Swanston, S. Mayers
Mount Hope (Trinidad & Tobago), St. Augustine (Trinidad )
64.062
Ventilator Associated Pneumonia: A 22-Month Prospective Observational Study
from a Tertiary Care Centre in United Arab Emirates
M. Rahman, R. Hashmey, S. Abuhasna
64.063
VRE Surveillance; the Challenge of Preventing Endemnicity in a Singapore
Teaching Hospital
T.M. Ng, K.L. Ooi, X.Y. Sun, R. Lin, D.A. Fisher
64.064
Clinical Characteristics of Permanent Pacemaker and Implantable DefibrillatorRelated Endocarditis: An Eleven Years Experience (1996-2006)
J. López-Contreras, N. Hernández, M.L. Gálvez, N. Benito,V. Pomar, R. Pericas,
A. Cotura, P. Domingo, M. Gurguí
Barcelona (Spain)
64.065
Prospective Study of Candida sp Bloodstream Infection Rates and Susceptibility
Profile in a Tertiary Hospital in Salvador, Brazil: 2003-2007
A.C. Bandeira, M.G. Barberino, K. Barreiro, C. Campos
Salvador (Brazil)
64.066
Implementation of Basic Infection Control Guidelines in Major Hospitals of
Karachi, Pakistan
M.R. Khanani, A. Agha, S. Ahmed, A.A. Siddiqui
Karachi (Pakistan)
64.067
Knowledge and Performance Toward Universal Precautions Among Nurses in
University-Affiliated Hospitals of Mazandaran, Iran
R. Ghasemian, N. Najafi
Sari (Iran)
64.068
The Effect of Extended-Spectrum Beta-Lactamase Production On Antimicrobial
Suceptibility Figures Among Escherichia coli and other Enterobacteriaceae Isolated in
one Year of Prospective Hospital Surveillance Program
Bologna (Italy)
Final Program
161
64.059
Session 65
12:30–13:30
PARASITOLOGY
Prevalence of Intestinal Parasites and Related Factors in Primary Schools Children,
Varamin City, Iran
Z. Aminzadeh, B. Hosseinzadeh
Tehran (Iran)
65.002
Health-Seeking Behavior and Out-of-Pocket Expenditure in Patients with Visceral
Leishmaniasis in Nepal
T. Shrestha
Kathmandu (Nepal)
65.003
A Survey on the Effects of Leishmania Major TSA -Encoded DNA Vaccine Against
Experimental Leishmaniasis in BALB/c Mice
F. Tabatabaie, F. Ghaffarifar, A. Dalimi Asl, Z. Sharifi
Tehran (Iran)
65.004
HIV-associated Cutaneous Dissemination of Visceral Leishmaniasis, Despite Negligible
Immunodeficiency. Failure of Liposomal Amphotericin B Administration, Followed by
Successful Pentamidine-Paromomycin Administration
R. Manfredi, B. Passarini, G. Marinacci, L. Calza
Bologna (Italy)
65.005
Use of Toxoplasma gondi Specific IgG Avidity Assay for Diagnosis of Acquired
Toxoplasmosis in Pregnant Women
A. El-Moamly, I. Al-Khalife, M. El-Swify
Ismailiya (Egypt), Riyadh (Saudi Arabia)
65.006
Transmission of Trypanosoma cruzi Infection by Organ Transplantation, Los Angeles
County, 2006
L. Mascola, H. Kun, A. Moore, F. Steurer, G. Lawrence, B. Kubak, S. Radhakrishna,
D. Leiby, R. Herron,T. Mone, R. Hunter, M. Kuehnert
Los Angeles, CA, Sacramento, CA, Atlanta, GA, Rockville, MD (USA)
65.007
School Prevalence Surveys on Soil Transmitted Helminths and Schistosomiasis,
Rwanda
R. Josh, K. Blaise, M. Denise, R. Eugene, R. Nadine, K. Gaspard, K. Corine,
M.A. Deville, A. Fenwick
Kigali (Rwanda), London (United Kingdom), New York, NY (USA)
65.008
Seroprevalence of Toxoplasma gondi Antibodies in HIV/Aids Patients and Healthy
Blood Donors in Port Moresby General Hospital, Papua New Guinea
L. John, I.H. Kevau, J. McBride, K.Wilson, J. Milan, G.Tau
Cairns, Melbourne (Australia), Port Moresby., Port Moresby (Papua New Guinea)
65.001
1 6 2 Final Program
Session 65
12:30–13:30
Simple Sensitive Diagnosis and Genome Analysis of Wuchereria bancrofti microfilariae
and Wolbachia endosymbiont Archived from Membrane Filters by Nested PCR
A. Bhumiratana, P.Wiboonjak, C. Sangkamanee, S. Koyadun, P.Yongyuth,
P. Mahannop
Bangkok, Nakhon Si Thammarat, Phangnga (Thailand)
65.010
Prevalence of Onchocerciasis and IgG3 Response among the population of Poli,
North Cameroon
M. Zamio Biloa
Yaounde (Cameroon)
65.011
Clinical Spectrum of 67 Cases of Toxoplasmosis in Tehran: 2000–2004
M. Tehrani Sharif, E. Khaksar, B. Hooshmand
Tehran (Iran)
65.012
The Epidemiology of Amebiasis in Mentally Retarded Institutions in Taiwan
H.H. Hsiao, C.L. Chen, J.J. Huang,T.M. Huang, C.H. Chen
Taipei (Taiwan)
65.013
Survey of Hydatid Cyst in Tabriz Slaughter House Killed Animals and Infected
Human Cases in Health Center of Tabriz in 2006–2007
M. Khabbaz
Tabriz (Iran)
65.014
Prevalence of Toxocara canis in Stray Dogs in Northern Iran
A. Daryani, M. Sharif, A. Amouei, F. Askarian, H. Ziaei, S.H. Gohardehi, R. Bastani
Sari (Iran)
65.015
CD 28 Gene Polymorphism and Plasma Concentration of Soluble CD 28 in Iranian
Patients with Visceral Leishmaniasis
S.H. Hashemi, M. Hajilooi, M. Fallah, B. Naghili
Hamedan,Tabriz (Iran)
65.016
Proteases Secreted by the Infective Larvae of Toxocara canis and Partial Purification of a
50kDa Protease
Y.L.P. Jayananda, S.B.P. Athauda, R.P.V.J. Rajapakse
Kandy (Sri Lanka)
65.017
Seropervalence Toxocariasis in Children Aged 2-15 Referring to the Hospitals and
Medical Centers in Zanjan, Iran During the Year 2007
A. Nourian, M. Amiri, A. Ataeian, A. Hanilo, N. Mousavinasab
Zanjan (Iran)
Final Program
163
65.009
Session 65
12:30–13:30
PARASITOLOGY
65.018
The Identification of Cryptosporidium Species by PCR-RFLP Analysis of the 18s
rRNA Gene
D. Dorostkar Moghaddam, M. Azami, R. Salehi, M. Salehi
Isfahan (Iran)
65.019
Epidemiology Study of Entamoeba histolytica/Entamoeba dispar in
Bloody Diarrhea in Iran
M. Rostami Nejad, K. Cheraghipour, E. Nazemalhosseini, E. Abdinia, M.Vahedi,
H. Dabiri, M.R. Zali
Hamadan,Tehran (Iran)
65.020
Rodents as Museum of Helminthic Parasites of Public Health Importance in
Punjab, India
N. Singla, L.D. Singla, R. Kaur
Ludhiana (India)
65.021
The Correlation Antibodies Antitoxoplasma - Histopatologic Repert in Subacute
and Acute Lymphoadenopathy
N. Como, E. Muço, D.H. Kraja, E. Meta, A. Kica, R. Petrela,V. Ostreni
Tirana (Albania)
65.022
Study of Prevalence of Echinococcus multilocularis Infection in Carnivores of
Moghan Plain, North West of Iran in 2007
M. Siavashi, M. Zarea
Tehran (Iran)
65.023
Biochemical Changes in the Fertile and Sterile of Hydatid Cyst Fluid in Sheep
S. Rouhani, A.Vatankhah
Tehran (Iran)
65.024
Relapse After Treatment with First Stage Drug in Human African Trypanosomiasis:
Contribution of Molecular Biology
L. Kohagne Tongue , F. Louis, N.F. Dologuele
Yaoundé (Cameroon)
65.025
The Distrubution of Intestinal Parasites Prevalance at Five Years of Sex and Species of
the Osmangazi University Medical Faculty
N.D. Dogan
Eskisehir (Turkey)
65.026
Seroepidemiology of Toxoplasma gondii in Workers of Slaughterhouse in
Zapopan, Jalisco
M.L. Galván-Ramírez, C.M. Flores Orozco, J.L. Soto Mancilla
Guadalajara, Jalisco, Ocotlan, Jalisco (Mexico)
1 6 4 Final Program
Session 65
12:30–13:30
Analysis of PGF2α Synthase in Old and New World Species of Leishmania
J. Majanja, B.K. Kubata
Nairobi (Kenya)
65.028
Diarrhoeagenic Protozoan Parasites in Rural Persons and Links to HIV Infection and
Drinking Water Sources
S. Zinyowera,V. Ruhanya, C. Berejena, N. Midzi, M. Mapingure,T. Mduluza,
P. Nziramasanga
Harare (Zimbabwe)
65.029
Effects of Intestinal Parasite Infections on Cardiovascular Functions
N. Dogan, K. Uzuner, S. Arkan
Eskisehir (Turkey)
65.030
Intestinal Schistosomiasis and Soil-Transmitted Helminthiasis in a Peri-Urban
Community in Rio De Janeiro State, Brazil
O.K. Seck, M.F. Gusmão, M.G.M. Barreto, M.T. Paulino, R.P. Igreja, M.S. Soares
Rio de Janeiro (Brazil)
65.031
Inherited Variability in Tumour Necrosis Factor Production and Potential Susceptibility
to Cutaneous Leishmaniasis in the Sri Lankan Population
T.N. Samaranayake, S.D. Fernando, R.W. Jayasekara,V.H.W. Dissanayake
Colombo (Sri Lanka)
65.032
Inherited Susceptibility to Cutaneous Leishmaniasis in Sri Lanka
T.N. Samaranayake, S.D. Fernando, R.W. Jayasekara,V.H.W. Dissanayake
Colombo (Sri Lanka)
65.033
Geographic Factors Associated to Trypanosoma cruzi Infection in Western Mexico
F. Espinoza-Gomez, O.A. Newton-Sanchez,V. Melnikov, A. Maldonado,
F. Rojas-Larios
Colima (Mexico)
65.034
Seroprevalence of Entamoeba histolytica Infection in China
X. Cheng,Y. Chen, B.Yang, M. Feng, L. Xu, H.Tachibana
Shanghai (China), Isehara (Japan)
65.035
Clinical Features of Cutaneous Leishmaniasis in Sri Lanka and Molecular
Identification of L. donovani as the Cause
H.V.Y.D. Siriwardana, H.A. Noyes, N.J. Beeching, A.R.Wickremasinghe,
M.L. Chance, P.A. Bates, N.D. Karunaweera
Colombo, Kelaniya (Sri Lanka), Liverpool (United Kingdom)
Final Program
65.027
165
Session 65
12:30–13:30
PARASITOLOGY
65.036
Establishing the Role of Latent Toxoplasmosis in the Ethiopathogenesis of
Schizophrenia
P.Yuksel, B. Kocazeybek, N. Alpay, C. Babur, R. Bayar, A.R. Karaköse, C. Aksoy,
M. Aslan, S. Mehmetali, S. Kilic, I. Balcioglu, O. Hamanca, O. Kucukbasmaci,Y.A. Oner,
A. Dirican
Ankara, Istanbul (Turkey)
65.037
Overexpression and Protective Role of Interleukin-6,Tumor Necrosis Factor-Alpha
and Nitric Oxides in Experimental and Clinical Ocular Toxoplasmosis
J. Prada,T. Ngo-Tu
Berlin (Germany), Hanoi (Vietnam)
65.038
Detection of Acanthamoeba in Tap Water and Contact Lens Cases Using PCR
P. Cho, M.V. Boost, S. Lai,W.M. Sun
Hong Kong (China)
65.039
Molecular Diagnosis of Babesia Infection Among Rodents Collected from the Offshore
Kinmen Island of Taiwan
C.M. Shih,W.C.Yu, L.L. Chao
Taipei (Taiwan)
65.040
Reactivity of Antibodies to Hookworm Excretory-Secretory Antigens from
Hookworm Infected Patients in Northern Nigeria
B.O.P. Musa, G.C. Onyemelukwe, A.A. Ahmad
Zaria (Nigeria)
65.041
Preliminary Analysis of the Molecular Phylogenetics of Toxocara canis (Nematoda:
Ascaridoidea) Using Nuclear Ribosomal Second Internal Transcribed Spacer
Sequences
A.J. Rodriguez-Morales, R.A. Barbella-Aponte, M. Arria
Valencia (Spain), Caracas (Venezuela)
65.042
Intestinal Parasites in Patients with Celiac Disease: A Clinical Study
M. Rostami Nejad, K. Rostami, E. Nazemalhosseini, M.R. Zali
Tehran (Iran), Birmingham (United Kingdom)
65.043
Preparation and Characterization of Live Attenuated Strain of L. major
A.R. Khabiri
Teharn (Iran)
65.044
Relationship Between Toxocariasis and Asthma: A Prospective Study Among
Peruvian Children
L. Getaz, F. Samalvides, J.P. Breña, C.P. Maguiña, E. Gotuzzo
Lima (Peru)
1 6 6 Final Program
Session 65
12:30–13:30
Epidemiologic Considerations About Visceral Leishmaniosis in Albania
R. Petrela, H. Hoxha, E. Kallfa, G.J. Lito, A. Kallfa, N. Como
Tirana (Albania)
65.046
Plasma Levels of Interferon-gamma, Interleukin-10, and Interleukin-12, Before and
After Treatment in Visceral Leishmaniasis
A. Khoshdel
Shahrekord (Iran)
65.047
Detection of Acute Toxoplasma gondii infection in early pregnancy by IgG-avidity and
PCR analysis
J. Iqbal, N. Khalid
Kuwait city (Kuwait)
65.048
A 6 Year Geohelminth Infection Profile of Children at High Altitude in Western Nepal
C. Mukhopadhyay, G.Wilson, K. Chawla,V.S. Binu, P.G. Shivananda
Gangtok, Manipal (India), Doha (Qatar)
65.049
Production of Monoclonal Antibody Against Toxocara cati Second Stage Larvae and
Its Application for the Detection of Circulating Antigens
M. Zibaei, S.M. Sadjjadi, B. Sarkari, S. Ishiyama , S. Uga
Khoram Abad, Shiraz (Iran), Kobe (Japan)
65.050
In Vitro Encystment of Entamoeba histolytica by Oxidative Stress and Oligoelements
H. Aguilar-Díaz, N. Moreno, J.P. Laclette, J.C. Carrero
Ciudad de México (Mexico)
65.051
Evaluation of Lower Molecular Mass (10-30KDa) T. Solium cysticerci antigen by Western
blotting for the diagnosis of neurocysticercosis in children
A.V. Subba Rao, P.D. Singhi, N. Khandelwal, N. Malla
Chandigarh (India)
65.052
Serodiagnosis of Neurocysticercosis in Children with the Use of T. solium cysticerci
Excretory Secretory Antigens by Elisa and Immunoblotting
A.V. Subba Rao, P.D. Singhi, N. Khandelwal, N. Malla
Chandigarh (India)
65.053
Quantitative Study of Structure-Activity Relationship (Q.S.A.R.) of Antimalarial
Compounds Isolated from Solanum nudum and Derivatives Synthesis
A. Pabón, A. Mesa, L. Zuluaga, F. Echeverri, S. Blair
Medellín (Colombia)
65.054
The Genome Project of Taenia solium
A. Garciarrubio, R.J. Bobes, J.C. Carrero, M.A. Cevallos, G. Fragoso,V.M. González,
M.V. José, A. Landa, C. Larralde, L. Mendoza, J. Morales-Montor, E. Morett, E. Sciutto,
X. Soberón, J.P. Laclette
Cuernavaca, Mexico, D.F. (Mexico)
Final Program
167
65.045
Session 65
12:30–13:30
PARASITOLOGY
Low Degree of Genetic Diversity Within and Among Taenia solium Cysticerci from
Natural Infected Pigs of Central Mexico
R.J. Bobes, G. Fragoso, M. Ávila, M.R. Reyes-Montes, E. Duarte-Escalante, R.Vega,
A. Aluja, J. Morales, C. Larralde, E. Sciutto
Mexico, D.F. (Mexico)
65.056
Intestinal Parasitic Infections Among Children and Their Medical Staff in a Romanian
Pediatric Care Unit
T.R. Olariu,T.R. Olariu, O. Cretu, I. Marincu, O. Jurovits, L.Tirnea, R. Neghina,
I. Iacobiciu, A. Koreck, C. Petrescu
Timisoara (Romania)
65.057
Investigations of Clinical and Demographical Findings of Children with Positive Stool
Specimen with Nonpathogenic Intestinal Parasitic Infections
E.C. Dinleyici, N. Dogan, S. Reyhanioglu
Eskisehir (Turkey)
65.058
American Cutaneuos Leishmaniasis in the Urban Area from Ilhéus Cit, Bahia State.
Characterization of Autochthones Human Cases and Risk Factors Associated
Y.B. Souza, P.D. Bevilacqua
Viçosa (Brazil)
65.055
1 6 8 Final Program
Session 66
12:30–13:30
ANTIBIOTICS AND RESISTANCE
Pattern of Organism and Antimicrobial Resistance Bacterial Enteric Pathogens from
Kashani Hospital of Iran
E. Moghtadai Khorasgani
Shahrekord (Iran)
66.002
Comparison of Gatifloxacin Versus Levofloxacin in the Treatment of Adults with
Bacterial Infections: A Double-Blind, Randomized Trial in China
P. Hu, Z.Yuan, X.D. Zhou, E.Q. Xiong, G.S. Qian, H. He, Z.H. Peng, H. Ren
Chongqing, Xian (China)
66.003
Nationwide Surveillance of Doripenem Susceptibility among Clinical Isolates in
intensive care units in Taiwan: SMART Program 2004 data
S.S. Jean, P.R. Hsueh,W.S. Lee, H.T. Chang, M.Y. Chou, I.S.Wang, J.H.Wang, C. Lin,
J.M. Shyr,W.C. Ko, J.J.Wu,Y.C. Liu,W.K. Huang, L.J.Teng, C.Y. Liu
Kaohsiung,Taichung,Tainan,Taipei County,Taipei,Taoyuan (Taiwan)
66.004
Odds Ratios of Antimicrobial Susceptibility in Nosocomial and Non-Nosocomial
Infections in Environments with Low and High Prevalence of Resistant Pathogens
A. Zalounina, M. Paul, K. Kofoed, S. Andreassen, L. Leibovici
Aalborg, Copenhagen (Denmark), Petah-Tiqva (Israel)
66.005
Application of Human Recombinant Granulocyte Coloni-Stimulating Factor (rHUG-CSF) Onto Patients with Medicamentally and Radiately Provoked Neutropenia and
Aplastic Anaemia
L. Gercheva, P. Lazarova, G. Kyuchukov, K. Metodiev
Varna (Bulgaria)
66.006
Susceptibility of Oral Anaerobic Bacteria to Fluoroquinolones of Various Generations
and Molecular Characterization of Resistant Strains
V.Tsarev, V. Chuvilkin , E. Ippolitov
Moscow (Russia)
66.007
Antibiotic Use in a Brazilian City
F. Del Fiol, S. Barberato Filho
Sorocaba (Brazil)
66.008
Bacterial Resistance in Argolis, Greece
K. Mitrakou, I. Mitrakos, G.C. Michalopoulos, E. Xounta, G. Mavras, M. Pavlaki,
F. Rozi
Argos (Greece)
66.009
Prevalence of Integrons in Malaysian Isolates of Antibiotic Resistant Bacteria
S.Y. Chia, S. Muniandy, N. Parasakthi
Final Program
66.001
169
Session 66
12:30–13:30
66.010
Risk Factors for Nephrotoxicity associated with Continuous Vancomycin Infusion in
Outpatient Parenteral Antibiotic Therapy
P.R. Ingram, D.C. Lye, P.A.Tambyah,W.P. Goh, V.H. Tam, D.A. Fisher
Singapore (Singapore), Houston,TX (USA)
66.011
Comparative Study of Piperacillin/Tazobactam and Cefepime in Cancer Patients with
Febrile Neutropenia
Y.M. Wi, D.R. Chung, J.H. Song, K.R. Peck
Seoul (Republic of Korea)
66.012
Bioprospecting for Antimicrobial Peptides
K. Philip, S.K. Sinniah, S. Muniandy
66.013
Evaluation Results of 21th Iranian External Quality Assessment Schemes (EQAS) of
Microbiology laboratories in 2007
M. Rahbar, M. Saremi, M. Mir Mohammadi Roodaki, R. Sabourian, S. Hekmat Yazdi
Tehran (Iran)
66.014
Multicenter Evaluation of Tigecycline Activity in India: Report from the SENTRY
Antimicrobial Surveillance Program (2006)
R. Jones, J. Bell, J.Turnidge, D. Mathai
Adelaide (Australia),Vellore (India), North Liberty, IA (USA)
66.015
Antibacterial and Antifungal Activity of Different Honeys
T. Ijaz, F.A. Ranjha, M.K. Shahzad, M.A. Khan, M. Imran, N. Ijaz, S. Ijaz
Lahore (Pakistan)
66.016
Multicenter Evaluation of Tigecycline: An in Vitro Update Against Clinical Pathogens
from Japan (2006-2007)
S. Kohno, K.Yanagihara, R. Jones, M. Castanheira
Nagasaki (Japan), North Liberty, IA (USA)
66.017
Study of Antibacterial Activity of a Green Alga, Caulerpa Sertularioides from
the Persian Gulf
S. Tajbakhsh, K. Zandi, P. Bahramian, M. Pooyan, K. Sartavi, G. Asayesh
Bushehr (Iran)
66.018
Clinical and Microbiological Efficacy of Continuous Versus Intermittent
Administration of Meropenem in Critically Ill Patients
I. Chytra, M. Stepan,T. Bergerova, E. Kasal, P. Pelnar, R. Pradl, A. Zidkova
Plzen (Czech Republic)
66.019
Longitudinal Analysis of Tigecycline Activity against US isolates of Enterobacteriaceae
and Acinetobacter spp. Based on Patient Location and Specimen Source
D.C. Draghi, M.K.Torres, C.Thornsberry, C.M. Pillar, M.J. Dowzicky, D.F. Sahm
Collegeville, PA, Herndon,VA (USA)
1 7 0 Final Program
Session 66
12:30–13:30
Dalbavancin Tested Against Staphylococcus spp. and Streptococcus spp. Isolates collected
from Five European Counties: Comprehensive DECIDE Program Results (2007)
D. Biedenbach, R. Jones
North Liberty, IA (USA)
66.021
In-vitro Activity of Ertapenem against Bloodstream Isolates of Bacteria at the
National University Hospital, Singapore
S.Vasoo,W.M.C. Ong, P.A.Tambyah, G. Kumarasinghe, K. Singh
Singapore (Singapore), Chicago, IL (USA)
66.022
Activities of Tigecycline against Clinical Isolates of Acinetobacter baumannii in Taiwan:
Broth Microdilution Method vs. Disk Diffusion Method
C.H. Liao, H.C. Kung, G.J. Hsu, P.L. Lu,Y.C. Liu, C.M. Chen, C.M. Lee,W. Sun,
T.N. Jang, P.C. Chiang
Chiayi, Kaohsiung, Pingtung,Taichung,Taipei,Taoyuan,Yunlin (Taiwan)
66.023
Nationwide Surveillance of in Vitro Activities of Tigecycline Against Clinical
Isolates of Resistant Gram-Negative Bacteria in Taiwan: Broth Microdilution
Method vs. the E-Test
C.T. Lu,Y.C. Chuang,W. Sun,Y.C. Liu,Y.J. Cheng, P.L. Lu, C.M. Chen, G.J. Hsu,
T.N. Jang, C.M. Lee
Changhua, Chiayi, Kaohsiung, Pintung,Taichung,Tainan,Taipei,Yilan (Taiwan)
66.024
Bacterial Resistance Patterns of Isolates from Various Body Sites:
The European T.E.S.T. Program
M. Renteria, M. Hackel, R. Badal, S. Bouchillon, B. Johnson, J. Johnson, D. Hoban,
M. Dowzicky
Schaumburg, IL, Collegeville, PA (USA)
66.025
Nationwide Surveillance of in vitro Activities of Tigecycline against ExtendedSpectrum-β-lactamase-Producing Enterobacteriaceae in Taiwan
C.H. Huang, Z.Y. Shi,Y.C. Liu,Y.J. Cheng, C.M. Chen,W. Sun, G.J. Hsu, P.L. Lu,
T.N. Jang, P.C. Chiang
Changhua, Chiayi, Kaohsiung, Pintung,Taichung,Taipei,Taoyuan (Taiwan)
66.026
In Vitro Potency of Tigecycline Against Pathogens from Most Common Body Sites:
A Study in Asia/Pacific Rim
R. Badal, M. Renteria, S. Bouchillon, B. Johnson, M. Hackel, J. Johnson, D. Hoban,
M. Dowzicky
66.027
Evaluation of 11 Antimicrobial Agents Against Australian Bacteremia Isolates:
The T.E.S.T. Program
R. Badal, S. Bouchillon, M. Hackel, J. Johnson, D. Hoban, B. Johnson, M. Renteria,
M. Dowzicky
Final Program
171
66.020
Session 66
12:30–13:30
66.028
Efficacy of Tigecycline Against Worldwide Levofloxacin-Resistant Pathogens
R. Badal, M. Renteria, S. Bouchillon, B. Johnson, M. Hackel, J. Johnson, D. Hoban,
M. Dowzicky
66.029
An Evaluation of Tigecycline and Comparators in Asia/Pacific Rim for Often Difficult
to Treat Pathogens
J. Johnson, D. Hoban, B. Johnson, S. Bouchillon, M. Hackel, R. Badal, M. Renteria,
M. Dowzicky
66.030
Tigecycline and Comparators Against Extended Spectrum Beta-Lactamase (ESBL)
Isolates Worldwide
M. Renteria, M. Hackel, J. Johnson, D. Hoban, R. Badal, B. Johnson, S. Bouchillon,
M. Dowzicky
66.031
Evaluation of Tigecycline in the United States Against Antimicrobial Resistant
Acinetobacter
R. Badal, J. Johnson, M. Renteria, D. Hoban, B. Johnson, S. Bouchillon, M. Hackel,
M. Dowzicky
66.032
Prophylactic Nurturing of Antibiotic Resistance Genes
S. Soleimani-Connolly, S.N. Connolly
Middlesbrough (United Kingdom)
66.033
Antibacterial Activity of Terminalia catappa Against Bacteria Isolated from Burn Wounds
and Comparison with Effects of Selective Antibiotics in vitro
M.M. Attarpour Yazdi, M. Kamalinejad
Tehran (Iran)
66.034
An AUC Based Method for Aminoglycoside Dosing Adjusting for Drug Excretion
During Infusion and Allowing Early Recognition of Drug Accumulation
M.R. Loewenthal
Newcastle (Australia)
66.035
Activity of Tigecycline against Clinical Pathogens Collected in Indonesia (2006)
J.D. Turnidge, J.M. Bell, D. Subekti, R.N. Jones, I.Yusuf, L. Kusumawati,
M.J. Dowzicky
Adelaide (Australia), Jakarta, Makassar, Medan (Indonesia), North Liberty, IA,
Collegeville, PA (USA)
66.036
Tigecycline Activity Against Isolates from Medical Centers Located in China, Hong
Kong and Taiwan (2006): A SENTRY Antimicrobial Surveillance Program Report
M. Chen, J.M. Bell, J.D.Turnidge, R.N. Jones, M.J. Dowzicky
Adelaide (Australia), Beijing (China), North Liberty, IA, Collegeville, PA (USA)
1 7 2 Final Program
Session 66
12:30–13:30
Antimicrobial Activity of Tigecycline Tested against Contemporary Bacterial Isolates
Collected in Australia (2006)
J.M. Bell, J.D.Turnidge, R.N. Jones, M.J. Dowzicky
Adelaide (Australia), North Liberty, IA, Collegeville, PA (USA)
66.038
An Asia/Pacific Rim Perspective of Enterobacteriaceae Multi-drug Resistant (MDR)
Isolates Against Tigecycline
B. Johnson, S. Bouchillon, M. Hackel, J. Johnson, M. Renteria, R. Badal, D. Hoban,
M. Dowzicky
66.039
Evaluation of Multidrug Resistant (MDR) Isolates Against Tigecycline: A Canadian
Perspective
M. Hackel, R. Badal, S. Bouchillon, B. Johnson, J. Johnson, D. Hoban, M. Renteria,
M. Dowzicky
66.040
One Year Survey and Resistance Analysis in 757 Isolates Causing Urinary Tract
Infections
A. Koteli, A. Kakoulidou, M. Andronoglou, S.Tsingene
Thessaloniki (Greece)
66.041
Impact of Educational Efforts on Antimicrobial Prescribing and Bacterial Resistance
Rates in a Community Hospital
O.H. DeTorres
Escondido, CA (USA)
66.042
Is Ciprofloxacin Effective in the Treatment of Mycoplasma Pneumonia? A Case
Report
S. Kalimuddin, M.L. Kang, B.H.Tan, J. Choo, H.N. Leong
66.043
Monitoring of Antibiotic Prophylaxis Usage in a Tertiary Care Hospital
R. Adhikary, B.N. Gokul, K.R. Kulkarni, M. Chakravarthy
Bangalore (India)
66.044
Synthesis and Antibacterial Activity of Piperazinyl Oxazolidinones Containing 5-(4methyl-1,2,3-triazole)
O.A. Phillips, E.E. Udo, M. Abdel-Hamid, R.Verghese
Safat (Kuwait)
66.045
Changing Trend of Antimicrobial Resistance Toward Salmonella Isolates of Nepal:
Findings of Antimicrobial Resistance Surveillance Program, Nepal
S. Malla, S.P. Dumre
Kathmandu (Nepal)
Final Program
66.037
173
Session 67
12:30–13:30
VIRAL HEPATITIS
A Comparison Research of Hepatitis B Virus Large Surface Protein with
HBV DNA Detecting
Z.L. Wu, X.D. Lu, X.Q. Zhong, L.F. Ling, G. Lin, G.C. Xiao
ShenZhen (China)
67.002
Trial of Lamivudine in Inactive HBsAg Carriers with Persistent Hepatitis B
Core IgM Antibody
H. Ali
Dohuk, Kurdistan Region (Iraq)
67.003
Therapy of Chronic Hepatitis C in Intravenous Drug Users—Efficiency and Problems
M. Bozic, K. Bojovic, M. Djonin-Nenezic, I. Milosevic
Belgrade (Serbia)
67.004
Nosocomial Chronic Viral Hepatitis
F. Sirmatel, H. Peksel, B. Gursoy
Bolu, Mardin, Sanliurfa (Turkey)
67.005
Sexual Transmission of Hepatitis C Virus Among Female Sex Workers in India
P. Barua, N. Laskar, G.K. Medhi, B. Apum, J. Mahanta
Dibruagrh, Dibrugarh (India)
67.006
Genotype Distribution in Chronic Hepatitis C Patients in Greece
G. Totos, M. Stamouli, D. Kairis, A. Michopoulou, I. Panagiotou
Athens (Greece)
67.007
A Study of Anxiety Status and Influencing Factors on Patients with
Chronic Hepatitis B
F.J. Du, H. Gao, F.L.Wang,Y.L He,Y.L. Zhao
Xi’an (China)
67.008
Psychological Stress, Cortisol and Immune Status in Patients with Chronic Hepatitis B
H.YingLI, G. Heng, Z.YingRen,W. Ke
Xi’an (China)
67.009
Association Between HLA-A, B, DRB1 Alleles and Susceptibility or
Resistance to Chronic Hepatitis B
A. Ramezani, M.R. Hasanjani Roshan, E. Kalantar, A. Eslamifar, M. Mohraz,
M. Banifazl, A. Aghakhani, J.Taeb , A.A.Velayati
Babol,Tehran (Iran)
67.010
Long Term Immune Response to Hepatitis B Vaccine in Haemodialysis Patients
A. Ramezani, A. Eslamifar, M. Mohraz, M. Banifazl, F. Ahmadi, S. Maziar, E. Razeghi,
E. Kalantar, M. Hazrati, A. Amirkhani, A. Aghakhani
Tehran (Iran)
Final Program
175
67.001
Session 67
12:30–13:30
VIRAL HEPATITIS
67.011
Intrafamilial Transmission of Hepatitis C Virus Infection in Iran (Markazi Province)
A. Fani, M. Sofian, P. Adeli ran-kuohi, M. Fathollahi, B. Eshrati, P. Fani,
A. Rostampoor
Arak (Iran)
67.012
Epidemiological Screening of Hepatitis E Virus in Bile Specimens from Livestock in
Northwest China
Z.J. Saho, J.H. Li
Xian (China)
67.013
Immunity to Hepatitis B Vaccine in Children Less Than 5 Years Vaccinated Using
Hepatitis B Vaccine Attending RCH Clinics Dar Es Salaam,Tanzania
J. Metodi, A. Said, E. Munubhi
Dar Es Salaam (Tanzania)
67.014
The Prevalence of Hepatitis B and Hepatitis C Among Street Children in Tehran, Iran
F. Fallah, H. Goudarzi, A. Karimi, G. Esllami, R. Radmanesh Ahsani
Tehran (Iran)
67.015
Assessment of the Selected Cytokines Among Patients Treated for Chronic Hepatitis
Type C
M. Dudziak, A. Zakrzewski, J. Kruszewski
Warsaw (Poland)
67.016
Efficacy of Pegylated Interferon Alpha-2a and Ribavirin Treatment in Chronic
Hepatitis C Patients Depends on Various Baseline Parameters and Early Viral Kinetics
P. Husa, P. Slesinger, H. Stroblova, A. Svobodnik, L. Husova
Brno (Czech Republic)
67.017
Prevalence of Hepatitis C Virus (HCV) Genotype 3a in the Infected Population of
Lahore, Pakistan
T. Ijaz, M.A. Khan, S.A. Jafri, F.A. Ranjha, K. Asim Mehmood , M. Imran,
M.K. Shahzad
Lahore (Pakistan)
67.018
Diagnosis Dilemma of Chronic Hepatitis
A. Zakrzewski, M. Dudziak, J. Kruszewski, M. Abramowicz
Warsaw (Poland)
67.019
Hepatitis B Virus in Chronically Infected Patients
M. Basaras, E. Arrese, S. Blanco, M. Sota, B. de las Heras, R. Cisterna
Bilbao (Spain)
1 7 6 Final Program
Session 67
12:30–13:30
Prevalence of Hepatitis C Virus (HCV) Genotypes in the Population of Brasilia, DF,
Capital of Brazil
S.F. Fonseca, G.B. Barra, L.F.R.Velasco, L.F. Abdalla, A.S.G. Cabral, S.S.S. Costa,
J.A.R.Vaz
Brasilia (Brazil)
67.021
Occult Hepatitis B Virus Infection Among Chronic Liver Disease Patients in the
United Arab Emirates
M.I. Al-Moslih, A. El Sayed, H.Youssef, A.A. El Majeed
Abu Dhabi, Sharjah (United Arab Emirates)
67.022
Evaluation of Prevalence of RT-PCR Based HCV Infection in Thalassemia and
Hemodialysis Patients in Kerman Province (Iran)
G. Hassanshahi, B. Esmaeilzadeh, M. Kazemiarababadi, A. Sadeghi
Rafsanjan (Iran)
67.023
Molecular Epidemiology of Hepatitis C Virus in Southern China
Y.Tan, M.Q. Li, Q.H.Wei, L.J. Chen, P.C. Chan, S.S. Lee
Hong Kong, Liuzhou, Guangxi , Liuzhou, Guangxi, (China)
67.024
Characterisation of Complete Hepatitis B Virus Genomes Isolated from Black
Southern Africans with HBV-associated Hepatocellular Carcinoma
M. Skelton, G. Kimbi, A. Kramvis, M.C. Kew
Cape Town, Johannesburg (South Africa)
67.025
Seroprevalence of Human Immunodeficiency Virus, Hepatitis B and C Viruses Among
Blood Donors in Chabahar, Iran
H. Jabbari, S. Karami, F. Fattahi, S. Jam, M. Mohraz
Chabahar,Tehran (Iran)
67.026
Phylogenetic Analysis of a Hepatitis C Virus Nosocomial Outbreak
M.L.C. Panait, A.M. Oprisoreanu, C. Szmal, R. Negrea, I. Codita, G.R. Oprisan
Bucharest (Romania)
67.027
Molecular Epidemiology of HCV Genotypes in Injecting Drug Users in Hong Kong
K. Lee, D. Chan, S.S. Lee
Hong Kong (China)
67.028
The Role of Predicitve Factors Over Virological Response in Patients with Chronic
Hepatitis C Treated with Pegylated Interferon alfa 2a
M. Gaseva, L.J. Ivanovski, C. Evtimovska,V. Grunevska, B.Tosevski, M. Dimzova
Skopje (Former Yugoslav Republic of Macedonia)
Final Program
177
67.020
Session 67
12:30–13:30
VIRAL HEPATITIS
The Study on the Characters of HBV-specific T Cells and Liver Damage
between HBeAg(+) and HBeAg(-) CHB Patients
G. Peng,W.Wu, X.Tan, Z. Sun,Y. Chen, Z. Chen
Hangzhou (China)
67.030
Clinical and Virological Features and Course of Acute Hepatitis B (AHB)
in Italy
E. Spada, M.E.Tosti, L. Romanò, C. Galli, A. Mariano, L. Germagnoli,
F. Dorigatti, M. Marinelli, A. Zanetti, A. Mele
Milano, Roma (Italy)
67.031
Incidence, Risk Factors and Control of Hepatitis A in Italy
M.E. Tosti, E. Spada, A. Mele
Rome (Italy)
67.032
Risk of Parenteral Transmitted Hepatitis Following Exposure to Invasive
Procedures (IP): Results from the Hepatitis Surveillance System in Italy
E. Spada, M.E.Tosti, A. Mele
Rome (Italy)
67.033
Evaluation of Early Predictors of Successful Therapy in HCV-Infected Patients
from Romania
C. Sultana, L. Manolescu, S. Ruta
Bucharest (Romania)
67.034
Genotyping and Viral Load Measurements in Patients with Major Thalassemia
and Positive Hepatitis C Virus Antibody in Mazandaran Province, Iran
F. Babamahmoodi, M. Kosarian, A.R. Babamahmmodi, M. Adnani
Sari,Tehran (Iran)
67.035
Silibinin May Abolish the Enhanced Expression of Fibrosis-Related Molecules
Cause by Hepatitis C Virus E2 Protein
M.J. Hsieh,T.Y. Chen,Y.S. Hsieh, H.L. Chiou
Taichung (Taiwan)
67.036
TGF-Beta1 Down-Regulates NKG2D Killer Activator Receptor
Expression on Peripheral Blood Cytotoxic Cells in Patients with
Chronic Hepatitis C
G. Par, A. Par,T. Berki, L. Palinkas, L. Szereday, J. Szekeres, A. Miseta,
G. Hegedus, B. Hunyady
Pecs (Hungary)
67.029
1 7 8 Final Program
Session 67
12:30–13:30
67.037
Seven-Year Experiences on Antiviral Treatment for Chronic Viral B and C Hepatitis
in Hungary—A Nation-Wide Study
A. Par, I.Tornai, F. Szalay, Hungarian Viral Hepatitis Treatment Study Group
Budapest, Debrecen, Pecs (Hungary)
67.038
PEG-IFN Plus Ribavirin Treatment Down-Regulates Serum Fibrosis Markers
Independently of Virological Response in Chronic Hepatitis C
A. Par, G. Par,T. Berki, P. Balogh, A. Miseta, G. Hegedus, B. Hunyady, A.Vincze
Pecs (Hungary)
67.039
Influence of Occult HBV Infection on Chronic Hepatitis C
M. Inglot, A. Szymczak,W. Rymer
Wroclaw (Poland)
67.040
Evolution of Interferon Therapy Resistance in Hepatitis C Virus
P.J. Planet, P.S. Pang, S.O. Kolokotronis, J.S. Glenn
Palo Alto, CA, New York, NY (USA)
67.041
Prevalence of Hepatitis G Virus Among Chronic Liver Disease Patients
and Voluntary Blood Donors in Kerala, India
R. Rajan,V. Balakrishnan, E.M. Elango
Kochi (India)
67.042
Hepatitis C Virus E2 Protein May Enhance the Expression of Fibrosis-Related
Molecules of Hepatic Stellate Cells
M.J. Hsieh,T.Y. Chen,Y.S. Hsieh, H.L. Chiou
Taichung (Taiwan)
Final Program
179
Session 68
12:30–13:30
PUBLIC HEALTH AND PREVENTION
Impact of a Community-Based Hand Hygiene and Safe Water Campaign on
Knowledge and Practices of Caregivers, Fayoum Governorate, Egypt, 2006
W. El-Shoubary, A. Lohiniva, M. Saied, N. El-Sayed, M.Talaat
Cairo, Fayoum (Egypt)
68.002
Seroprevalence of Blood-Borne Infections Among Blood Donors in Venezuela,
2001–2002
J.A. Benitez, A.J. Rodriguez-Morales
Maracay,Trujillo (Venezuela)
68.003
Progress Towards the Global Prevention of Hepatitis B
S.T. Wiersma, M. Gacic-Dobo, C. Shapiro
Geneva (Switzerland), Atlanta, GA (USA)
68.004
Nonpharmaceutical Interventions Implemented by US Cities During the
1918–1919 Influenza Pandemic
H. Markel, A. Stern, M. Cetron
Atlanta, GA, Ann Arbor, MI (USA)
68.005
Legionella Pollution in Cooling Tower Water of Air Conditioning System in
Shanghai, China
H. Lin
Taizhou (China)
68.006
Cellular Automaton Model for Epidemiology with Vaccination Strategy
S. Rajasekaran
Chennai (India)
68.007
Knowledge and Practice about Aids, Hepatitis B and C in Barbers
B. Ataei, A. Saidi, N. Kassaian, Z. Nokhodian, M. Jalali
Isfahan (Iran)
68.008
General Morbidity Profile of Rural and Periurban Population in Selected
Localities of Patna District: Household Survey
G. Kumari, R.A.M. Singh,V.K. Saxena
Delhi, Patna (India)
68.009
Investigation of (DMF) Index in First and Second Grade of Elementary School
in Fars Province, Iran, (2006–2007)
R. Bahadorikhalili
Shiraz (Iran)
68.001
1 8 0 Final Program
Session 68
12:30–13:30
Knowledge, Attitudes and Behavior Towards Antibiotic Use Among Parents in
Al-Ain City, United Arab Emirates
A.Tenaiji, K. Al Redha, F. Khatri, S. Darmaki, S. Hosani, M. Al Neaimi, A. Khan,
R. Hashmey
68.011
Prescribing Habits and Associated Factors in the Event of the New Antimalarial
Treatment Policy in a Rural Ugandan Hospital
J.A. Achan, P. Ucakachon, J. Nakayaga
Kampala (Uganda)
68.012
Comprehensive Family Hygiene Promotion in Peri-Urban Cape Town:
Gastrointestinal and Skin Disease Reduction in Children Under Five
E. Cole, M. Hawkley, J. Rubino, K. McCue, B. Crookston, J. Dixon
Montvale, NJ, Provo, UT, Salt Lake City, UT (USA)
68.013
Knowledge, Attitudes and Intended Behaviour of Hospital Health Care Workers
Around Pandemic Influenza
H. Seale, C.R. MacIntyre, R. Booy, J. Leask
Sydney (Australia)
68.014
Factors Associated with Maternal Mortality in Nyakabande Subcounty,
Kisoro District in Uganda
J.K. Kabami
Mbarara (Uganda)
68.015
Vaccine Preventable Zoster Burden of Illness and Health Care Resourse Utilization:
An Australian Perspective
A.N. Stein, C.R. MacIntyre, H. Britt, C. Harrison, E.L. Conway, A. Cunningham
Melbourne, Sydney (Australia)
68.016
Health Behaviour and Infectious Disease Risk in Travellers Departing Australia
A. Heywood, R.Watkins, K. Nilvarangkul, S. Iamsirithawan, C.R. MacIntyre
Perth, Sydney (Australia), Bangkok, Khon Kaen (Thailand)
68.017
High Rate of Recent Infections in International Travelers Departing Bangkok
S. Pattanasin, A. Heywood, S. Iamsirithaworn, R. Buathong, H.Yang, R.Watkins,
C.R. MacIntyre
Perth, Sydney (Australia), Nonthaburi (Thailand)
68.018
Evaluation of Maternal and Child Health Services at Block PHC Harduaganj,
Aligarh, (UP)
S. Singh, D.C. Jain, R.C. Chaddha
Aligarh, Delhi (India)
Final Program
68.010
181
Session 68
12:30–13:30
PUBLIC HEALTH AND PREVENTION
68.019
Knowledge, Attitudes and Practices About Measles Among Mothers in Urban Slum
Area of District Aligarh, UP
S. Singh, U. Chawla
Delhi (India)
68.020
Factors Associated with Preventive Behavior on Dengue Hemorrhagic Fever Among
Family Leaders in One Sub-District of Bangkok,Thailand
C. Chanyasanha, S.Teetipasatit, S. Sujirarat,W. Kaewpan
Bangkok (Thailand)
68.021
The Rapid Dispensing and Delivery of Oseltamivir API during Influenza Pandemic
Phase: An Exercise Experience in Taiwan
S.E.Yang,Y.C. Chih, S.M. Chou, C.H. Chen
Taipei (Taiwan)
68.022
Pandemic Influenza Preparedness: is the Community Really Prepared?
H. Marshall, P. Ryan, D. Roberton, J. Street, M.Watson
Adelaide (Australia), Dunedin (New Zealand)
68.023
Potential Cost Impact in the Netherlands Due to Different Waning Patterns of
Cervical Cancer Vaccines
R.M. Rogoza, D. Debicki, M. Kohli
Burlington (Canada)
68.024
Successful Experience of Harm Reduction Program in Taoyuan County
S.R. Lin,T.M. Huang, H.C. Huang, L.C. See
Taoyuan County (Taiwan)
68.025
Prevalence of Infectious Diseases Among Immigrants Detected in Kuwait
A. Sher, S.A. Latif, J. Iqbal, P.R. Hira,Y. Al-Mandaka, R.A. Al-Owaish, S. Al-Mufti
Toronto (Canada), Kuwait (Kuwait)
68.026
Coping Strategies for Financial Burdens in Families with Pneumonia
N.I. Alamgir, A. Naheed, R.J. Khan, S.P. Luby
Dhaka (Bangladesh), California, CA (USA)
68.027
Baseline Assessment of knowledge, Attitude and Practice of Population in a Rural
Community in Bangladesh about Dog Bite and Treatment Seeking Behaviour
R. Rashid, A.A. Sayeed, A. Bashar, M.R. Rahman, M.A. Faiz
Chittagong, Dhaka (Bangladesh)
68.028
Epidemiology of Hospitalizations Due to Pneumonia in Brazil, 2000 to 2006
E.N.C. Barros, R. Malaguti, L.Z. Daufenbach, M.A. Millington, M.L. Carvalho
Brasilia (Brazil)
1 8 2 Final Program
Session 68
12:30–13:30
Evaluation of Local Preparedness for Influenza Pandemic in Taiwan
C.C. Chang,Y.M. Chou, C.H. Chen, S.M. Chou, M.S. Lu, C.R. Du
Taipei (Taiwan)
68.030
Comprehensive Family Hygiene Promotion in Peri-Urban Cape Town: Reduction
of Respiratory Illness in Children Under Five
E. Cole, B. Crookston, J. Rubino, K. McCue, M. Hawkley, J. Dixon
Montvale, NJ, Provo, UT, Salt Lake City, UT (USA)
68.031
Educational Lecture Contributed to Control the Outbreak While It Did Not Solve
Insecurity of Health Care Providers in a Long-Term Care Facility
Y.Yoshida,Y. Kumagai,Y. Kumagai, K. Shikoshi,T. Dazai
Tokyo (Japan)
68.032
Microorganisms in Wastewater Reused for Irrigation in a Mexico City Periurban Area
M. Mazari-Hiriart, A.C. Espinosa García, G. Castillo,Y. López Vidal, M.J. Aguilar
Medina, R. Arredondo Hernández
México, Distrito Federal (Mexico)
68.033
Solar Radiation and Enteric Virus Presence in Irrigation Water
A.C. Espinosa-Garcia, M. Mazari-Hiriart
Mexico (Mexico)
68.034
Fear, Stress, and Reported Pandemic Influenza Response among University Students
in the US
V. Perez, A.E. Aiello, G.F. Murray, R. Coulborn, A.S. Monto
Ann Arbor, MI (USA)
68.035
Expanding Corticosteroid Use in the Developing World as a Factor in the
Epidemiology of Emerging and Reemerging Infectious Diseases
M.L. Lyon
Canberra (Australia)
68.036
Female Genital Mutilation: Medical Complications of a Human Right Violation
P. Karimi, S.Yari, N. Loghmani
Tehran (Iran)
68.037
Childhood Infections and Vaccination History as a Risk of Multiple Sclerosis
P. Karimi, A. Bayati, M. Mehrabi
Tehran (Iran)
68.038
World Rabies Day: A Collaborative Initiative to...Make Rabies History!
C.A. Hanlon, P.J. Costa, A.Tumpey, S. Cleaveland, K. Doyle, D.J. Briggs
Midlothian (United Kingdom), Atlanta, GA, Manhattan, KS (USA)
Final Program
68.029
183
Session 69
12:30–13:30
EPIDEMIOLOGY OF BACTERIAL INFECTIONS
Investigation of Common Microorganisms in Patients with Brain Abscess
G. Eslami, F. Fallah, M. Lotfi, M. Golshani, H. Goudarzi
Tehran (Iran)
69.002
Incidence of Brucellosis in Shazand County, Iran, 2006
M.R. Hosseini, M. Sadeghi, E. Khondabi, H. Bakhshali, A. JamalOmidi
Shazand (Iran)
69.003
A Large Outbreak of Water-Borne Typhoid Fever Attributed to Contaminated Well
in a Coastal City, China
H. Lin
Taizhou (China)
69.004
Epidemiological Risk Factors of Urban Leptospirosis in North Chennai
(Tamil Nadu)—A South India Study
N. Loganathan, S. Shivakumar
Chennai (India)
69.005
A Seroepidemiologic Survey of Brucellosis in Human and Animals in Birjand,
East of Iran
S. Bokaie, L. Sharifi, H. Alizadeh
Tehran (Iran)
69.006
Epidemiology and clinical predictors of GAβHS among students in Alexandria, Egypt
M. Abdel Moneim, M. Hashish
Alexandria (Egypt)
69.007
Seroepidemiology of Helicobacter pylori Infection Among Health Care Workers
M. Metanat, B. Sharifi-mood, S. Izadi, M. Miradi, A. Ghorbani-Vaghei, S.H. Dawudi,
F. Fayyaz-Jahani
Zahedan (Iran)
69.008
High Rate of Meningococcal Disease in Baja-California, Mexico: An Unknown
Endemic Disease with a Rate Similar to the USA
E. Chacon-Cruz, J.L. Lopez-Viera, C.A. Lara-Muñoz, R.M. Rivas-Landeros,
M.C. Duran-Hernandez, M.L.Voelker, J.A. Hurtado-Montalvo
Tijuana (Mexico)
69.009
Prevalence and Predictors of Methicillin-Resistant Staphylococcus aureus (MRSA) and
Extended-Spectrum Beta-Lactamase (ESBL) Gram-Negative Bacteria at Hospital
Presentation in Singapore
S. Pada, D. Lye, P. Krishnan, J. Chan, S.P. Chan, G. Cham, B.S. Ang,Y.S. Leo
69.001
1 8 4 Final Program
Session 69
12:30–13:30
A large point-source outbreak of Salmonella typhimurium Phage Type 9 in
Sydney, Australia, March 2007
T. Mannes, L. Gupta, A. Craig, A. Rosewell, C. Aimers-McGuiness, J. Musto, Q.Wang
Sydney (Australia)
69.011
Prevalence of Beta Hemolytic Group Streptococci Among Elementary School
Children in Zanjan
B. Amini
Zanjan (Iran)
69.012
Meningococcal Disease Epidemiology in Asia
J. Leimkugel, L.J. Silva, G. Pluschke
Siena (Italy), Basel (Switzerland)
69.013
Epidemiological Characterization of Clostridium difficile Strains in Shanghai, China
H. Huang, S.Wu, M.Wang,Y. Zhang, H. Fang, A.C. Palmgren, A.Weintraub,
C.E. Nord
Shanghai (China), Stockholm (Sweden)
69.014
Massive Salmonella Poisoning in a Prefecture of Central Greece, Incidence Detailed
Presentation
E.Vlachaki-Taveli, A. Anastassiou, P. Patra, K. Katsiardanis, K. Kouraki, D. Krikou,
E. Papadopoulos, A. Gerovassili, G. Mitsiou
Larisa,Volos (Greece)
69.015
Emergence of Clonally Related SHV-5 ESBL-producing Escherichia coli Strains
in the Community
J.Vranes, B. Bedenic, A. Bauernfeind
Zagreb (Croatia), Munich (Germany)
69.016
Botulism—A Risk of Traditionalist or Underdeveloped Countries?
S. Draghici,V. Coldea, I. Lenard
Oradea (Romania)
69.017
Validation of a Manual Blood System and the Distribution of Organisms Causing
Bacteremia in a Resource-Limited Setting, SHCH, Phnom Penh, Cambodia
R. Seilavath, L. Kruy,T. Sopheak, S.Teav, C. Kham, E.Vlieghe, L. Lynen, J. Jacobs
Antwerp (Belgium), Phnom Penh (Cambodia)
69.018
Identification of Class 1 Integron of Salmonella typhimurium From Street Foods
in Jakarta, Indonesia
D.E. Waturangi,V. Gustiani
Jakarta (Indonesia)
Final Program
69.010
185
Session 69
12:30–13:30
EPIDEMIOLOGY OF BACTERIAL INFECTIONS
Epidemiology of MRSA in Children with Allergy
I. Kuznecovs, I. Joksta, S. Kuznecovs, K. Jegina
Riga (Latvia)
69.020
Escherichia coli Pathotypes Isolated in Inflammatory Bowel Diseases and Oncological
Diseases of Gastrointestinal Tract
M. Kmetova, K. Curova, L. Gombosova, M. Zakuciova, I. Lazurova, M. Sabol,
L. Siegfried
Kosice (Slovakia)
69.021
Carriage of Staphylococcus cureus in Cats and Their Owners
M.V. Boost, S.P.Wong, M.M. O'Donoghue
Hong Kong (China)
69.022
Imported Baby Corn Causing Outbreaks of Shigellosis in Denmark and Australia
H.C. Lewis, S. Ethelberg, K.E.P. Olsen, M. Lisby, S.B. Madsen, M. Kirk, R. Stafford,
K. Ungchusak, K. Mølbak
Brisbane, Canberra (Australia), Copenhagen (Denmark), Nonthaburi (Thailand)
69.023
Overlook on Epidemiology and Causative Agents of Ricketsia in Adults in Albania
N. Çomo, E. Muço, D.H. Kraja, A. Kica, E. Meta, K. Duraku
Tirana (Albania)
69.024
100 Years of Trachoma in the State of Sao Paulo, Brazil
E.J.A. Luna, N.H. Medina, M.A. Mauricio
Sao Paulo (Brazil)
69.025
Study of Severe Community-Acquired Pneumonia in Adults—Etiology, Prognosis, and
Antibiotic Therapy
S. Hakoda, N. Matsuo, H. Shinya, S. Kiuchi
Kobe, Osaka (Japan)
69.026
A Four-Year Prospective Observational Study of Bacteremias and Fungemias in a
Large,Tertiary Care Hospital of Northern Italy
Bologna (Italy)
69.027
Outbreak of Halophilic Vibrio Infections Associated with a
Major Environmental Disaster
O. Oluwatade, S. Hand, L. Mena
Jackson, MS (USA)
69.019
1 8 6 Final Program
Session 69
12:30–13:30
69.028
A Serological Follow-Up Study of Acute Q Fever Infection
M.N. Hung, P.Y. Shu, M.Y. Hou, P.S. Lin, C.C. Lin, L.J. Lin, H.Y. Lu,Y.C. Liu
Kaohsiung ,Taipei (Taiwan)
69.029
Epidemiology, Invasiveness and Comparative Proteomic Analysis of Group B
Streptococcus (GBS) of Indian Origin
A.K. Johri, P.Yadav, A. Ali, H. Jaint, M. Dua, G. Mehta
New Delhi (India)
69.030
Comparison Between Official Figures and Exact Incidence Rate of Human Brucellosis
in Qom Province of Iran
A.R. Bahonar, M. Dakhili
Tehran (Iran)
69.031
Escherichia coli Isolates from Cases of Japanese Travelers with Reported Diarrhea
K. Ito, M. Shigematsu
Tokyo (Japan)
Final Program
187
Session 70
12:30–13:30
NEW APPROACHES TO BACTERIAL AND FUNGAL DIAGNOSTICS
70.001
Differentiation Bacterial from Viral Infection-Advantage of Procalcitonin
H. Khatib, A. Bajraktarevic, A. Skopljak, M. Miokovic, A. Djurdjevic-Djulepa,
I. Kalkan, Z. Jatic, A. Semic, B. Djukic
Sarajevo (Bosnia and Herzegovina), Doha (Qatar), Manchester (United Kingdom)
70.002
Diagnostic Value of Brucella ELISA (IgG and IgM) in Patients with Brucellosis in
Kashan, Iran, 2004
K. Esalatmanesh, Z. Soleimani, A. Soleimani
Kashan (Iran)
70.003
Prevalence of Typhoid Fever in Kathmandu Valley and Its Rapid Diagnosis by
Detection of IgM Antibodies, Using Commercial Kit
J.P. Ghimire, R.R. Upadhyay
Kathmandu (Nepal)
70.004
Detection of E.coli O157:H7,V.cholerae, and S. typhimurium by Multiplex PCR
S.L. Mousavi, I. Rasooli, S. Nazarian, J. Jafar Amani
Tehran (Iran)
70.005
Multiplex Technology for Detection Respiratory tract Infection in Clinical Specimens
X.D. Lu, L.Z.Yang, J. Liu, L. Huang, Q.Wang
ShenZhen (China)
70.006
Evaluation of Agglutination as Serodiagnosis Test in Brucellosis
B. Asghari
Karaj (Iran)
70.007
Pleural Fluid Cholesterol and Bilirubin Value in Diagnostic of Exudative from
Transudative Pleural Effusion
B. Ataei, A. Araghi, N. Kassaian, Z. Nokhodian, I. Karimi
Isfahan (Iran)
70.008
Procalcitonin, C-reactive Protein ESR and WBC Count: Marker of Sepsis in
Burn Patients
M. Barati, F. Alinejad, M.A. Bahar, M. Satar Zadeh Tabrisi, N. Bodohi, H. Karimi
Tehran (Iran)
70.009
Evaluation of Enteroaggregative Escherichia coli (EAEC) Isolates by Multiplex PCR
Among HeLa Cells Adherent Isolates
S. Bouzari, A. Davoudabadi, M. Abaszadeh, A. Jafari, M. Oloomi
Tehran (Iran)
70.010
Rapid Detection of BlaShv ESBL in Blood by Real Time PCR
S. Palasubramaniam, S. Muniandy, N. Parasakthi
Kuala Lumpur., Kuala Lumpur (Malaysia)
70.011
Survay of Cerebrospinal Fluid (CSF and C-Reactive Protein (CRP) for
Differentiation of Bacterial and Viral Meningitis in Loghman Hakim, Aliasghar
and Valiasr Hospitals of Zanjan
D.R. Asadi, B. Amini
Zanjan (Iran)
1 8 8 Final Program
Session 70
12:30–13:30
Comparison of Fine Needle Aspiration Cytology with Excisional Histology in
Diagnosis of Neck Masses
M. Zangeneh, N. Shariati, M. Jamshidi Makiani, S.D. Siadat, M.Yarjanly,
G. Manshoory
Bandar Abas,Tehran (Iran)
70.013
Procalcitonin in Early Detection of Postoperative Infectious Complications.
The Comparison with a Set of Cytokines, Soluble Cytokine Receptors and
Acute Phase Proteins
P. Maruna, R. Frasko, J. Lindner
Prague (Czech Republic)
70.014
Diagnostic and Prognostic Value of Procalcitonin in Patients with Sepsis
O. Gunal, F. Ulutan
Ankara (Turkey)
70.015
Analysis of Bordetella pertussis Agglutinin Titer in the Patients with
Adolescent/Adult Pertussis
H. Kamano,T. Mori, H. Maeta, N. Kishimoto,T. Katami, M. Sato, K. Kamachi,
Y. Arakawa
Takamatsu,Tokyo (Japan)
70.016
Application of An Innovative Seminested PCR Test for Identification and Detection of
Ten Medically Important Candida Species
L.T.L. Than, K.P. Ng, P.P. Chong, H.F. Seow
Kuala Lumpur, Serdang (Malaysia)
70.017
Variation in Pilus Encoding Gene Cluster between O1 and Non-O1 Serogroups
of Vibrio cholerae in Iran
H. Mohammadi Barzelighi, B. Bakhshi, A. Rastegar Lari, M.R. Pourshafie
Tehran (Iran)
70.018
Introduction of a New Housekeeping Gene Sequences for Rapid Identification
of Vibrio cholerae Strains in the Clinical Samples
A. Dashtebani, B. Bakhshi, M. Oskui, M.R. Pourshafie
Tehran (Iran)
70.019
Bacterial DNA Load in Cerebrospinal Fluid During Treatment of Bacterial Meningitis
N.V.T. Tran, M.H. Nguyen, J. Farrar, C. Schultsz
Ho Chi Minh City (Vietnam)
70.020
A Comparative Western Immunoblot Antibody Titration Test for Evaluation of
Bartonella Therapy
W.D. Hardy, Jr., E.E. Zuckerman
Franklin Lakes, NJ (USA)
Final Program
189
70.012
Session 70
12:30–13:30
NEW APPROACHES TO BACTERIAL AND FUNGAL DIAGNOSTICS
70.021
Development of a Slide Latex Agglutination Assay for Identification and Confirmation
of Burkholderia pseudomallei from Cultures
S. Jeyanthi, J.Thimma, J.Vadivelu, C.S. Hung
70.022
Pneumocystis jiroveci Pneumonia (PCP) Diagnosis by Direct Fluorescent Antigen
Detection
W. Wootta, P. Panyaruggit, P. Sawanpanyalerd
Nonthaburi (Thailand)
70.023
Construction of the Internal Controls Using the Same Primers of the Target to Verify
PCR and QPCR Results for Diagnosis
P. Hung Van,V.D. Xuyen An, H.T.Thuy Loan, H. Hieu Ngoc, L.Thuy Quyen
Ho Chi Minh City (Vietnam)
70.024
Variations of Procalcitonin Serum Levels in Neonatal Period
G. Corona, G. Giogianni, S. Aversa, N. Decembrino, A. Artemisia,V. Cordaro, I. Barberi
Messina (Italy)
70.025
A Rapid and Simple Dry-Reagent Biosensor for Visual Detection of Amplified DNA
Using Microsphere Based Lateral Flow Technology
A.L. Chua, K. Balqis, B.H. Lim, M. Ravichandran, P. Lalitha
Kubang Kerian (Malaysia)
70.026
Enhanced Patient Serum Immunoreactivity to Recombinant Mycobacterium tuberculosis
CFP32 Produced in the Yeast Pichia Pastoris Compared to Escherichia coli and Its
Potential for Serodiagnosis of Tuberculosis
M.R. Barbouche, C. Benabdesselem , M.D. Fathallah, R.C. Huard , H. Zhu,
M.A. Jarboui, J.L. Ho, K. Dellagi
Tunis (Tunisia), New York, NY (USA)
70.027
One Year Experience of APTIMA COMBO 2 Transcription Mediated Assay (TMA)
for Detection of Chlamydia trachomatis and Neisseria gonorrhoea in a Large Private
Pathology Laboratory in Queensland
P. Lowe, P.B. Bartley, P. O'Loughlin, D. Drummond, R.Vohra
Brisbane (Australia)
70.028
Application Molecular Methods on Escherichia coli and Ornithobacterium rhinotracheale
Infectious in Commercial Flocks of Southern Khorasan Province in Iran
M. Farhoodi, M. kianizadeh, M. Banani, R.Toroghi, S.A. Pourbakhsh , H. Farzin ,
A. sadrebazzaz
Mashhad (Iran)
70.029
Comparative Evaluation of Eight Methods for the Detection of Methicillin-Resistant
Staphylococcus aureus (MRSA)
H. Al-Talib,Y.Y. Chan, A. Al-Khateeb, H. Habsah, K. Al-Jashamy, M. Ravichandran
Kelantan (Malaysia)
1 9 0 Final Program
Session 71
12:30–13:30
VIRAL DIAGNOSTICS
Detection of the Rate and Genotyping of Hepatitis C Virus (HCV) Infection in
Haemophilia and Thalassemia Patients in Iran
N.S. Naghavi, K. Samimi Rad, M. Salehi, R. Nategh , M. Shanesazzadeh
Isfahan,Tehran (Iran)
71.002
Analysis of Ocular Disease by Laboratory Surveillance from May to September 2007
in Incheon, Korea
M.Y. Lee, H.Y. Kim,Y.W. Kong, B.Y. Oh, K.W.Whang,Y.J. Koh, J.H. Kim, S. Jegal,
J.M. Lee, J.M. Go,Y.H. Kim,Y.S. Chung
Incheon, Seoul (Republic of Korea)
71.003
Detection and Identification of Human Metapneumovirus Infection in ShenZhen,
China
X.D. Lu, C.D. Lu, Q. Wang, Y.H. Lu, J. Liu
ShenZhen (China)
71.004
Viral Hepatitis-Serologic Patterns
S. Bisinova-Eftimova, S. Miskova, S.Trajkova, R. Stojanova,T. Nedelkova, M. Alceva
Veles (Former Yugoslav Republic of Macedonia)
71.005
Role of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) as a Better Tool
for Early Diagnosis of Human Rabies
B. Mishra, M. Biswal, R.K. Ratho
Chandigarh (India)
71.006
Development of Serodiagnostic Method for the Detection of Serotype-Specific AntiCoxsackievirus Antibodies
M.D. Mavrouli, N. Spanakis, A.Tsakris, J.G. Routsias
Athens (Greece)
71.007
Real-time Diagnosis and Monitoring of Cytomegalovirus Infections Using TaqManMGB Probe Technology
S. Pholampaisathit
Nonthaburi (Thailand)
71.008
Evaluation of Different Storage Conditions on Detection of Influenza A Virus
Subtyping by Multiplex PCR Assay
W. Kania, A.I. Susanti,T. Retno, G.T. Brice
Jakarta Pusat (Indonesia), Singapore (Singapore)
71.009
Virological and Immunological Monitoring of Human Cytomegalovirus Infection in
Heart and Small Bowel/Multivisceral Transplantation
T. Lazzarotto, A. Chiereghin, L. Gabrielli, A.D. Pinna, A. Lauro, P. Monari, S. Pop,
L. Potena, M.P. Landini
Bologna (Italy)
Final Program
191
71.001
Session 71
12:30–13:30
VIRAL DIAGNOSTICS
Detection of Hepatitis B Virus DNA in Oral Fluid by Using an
Optimized Nested PCR
M.I. Micalessi, C. Gérard, I.Thomas, P. Michielsen, P.Van Damme, R.Vranckx,
B. Brochier
Antwerp, Brussels (Belgium)
71.011
Screening for Influenza A H5N1 Haemagglutinin and Neuramidase Mutations
Using the New Alignment & Mutation Analysis Tool in Bionumerics
B. Pot, J. Goris, M.Vauterin, K. Janssens, P.Vauterin, L.Vauterin
Sint-Martens-Latem (Belgium)
71.012
Universal Virus Detection
C. Uhlenhaut, A.M. Sierra-Honigmann, S. Nanda, S.Tang, P.R. Krause
Bethesda, MD (USA)
71.013
Molecular Diagnosis of Common Viral Infectious Diseases Based on
Real-Time PCR
N. Mohamed, J. Bloomberg
Khartoum (Sudan), Uppsala (Sweden)
71.014
Detection of Minute Changes in Influenza Genome Fragments by Single-Strand
Conformational Polymorphism Technique
B. Gromadzka, B. Szewczyk, K. Smietanka, Z. Minta
Gdansk, Pulawy (Poland)
71.015
Evaluation of Two Commercial Enzyme Immunoassays for Rapid Detection of
Noroivrus Antigen in Human Stool Specimens
X.L. Bai, S.H. Lim, E.H. Seng,W.L. Loke, K.P. Chan
71.016
The Loop-Mediated Isothermal Amplification-Based Diagnostics for
Monkeypox Virus Infection
I. Iizuka, M. Saijo,Y. Ami,Y. Suzaki, N. Nagata, H. Hasegawa,T. Shiota,
M. Ogata, K. Sakai, S. Fukushi,T. Mizutani, I. Kurane, S. Morikawa
Tokyo (Japan)
71.010
1 9 2 Final Program
Session 72
12:30–13:30
MYCOBACTERIAL PATHOGENESIS, IMMUNOLOGY AND VACCINES
Analysis of Compensatory ahpC Promoter Region Mutations and Relative
Fitness of Inh-Resistant M.Tuberculosis
A. Mache ,Y. Mengistu, S.E. Hoffner, D.A. Anderson
Addis Ababa (Ethiopia), Stockholm (Sweden)
72.002
Immunophenotyping Analysis of Peripheral T and B Lymphocytes in Patients with
Chronic Pulmonary Tuberculosis
A. Garibay-Escobar, P.C. Gastélum-Aviña, C.Velázquez, J. Hernández
Hermosillo (Mexico)
72.003
Neonatal BCG Bacteremia - Thailand 2006-2007
N. Marin, C. Pittayawonganon, P.Thammawijaya,W. Kiatkulwiwat, P. Prapasiri,
H. Baggett, L. Peruski, S.Thamthitiwat
Nakhon Phanom, Nonthaburi (Thailand)
72.004
The PPE Protein Rv1196 of Mycobacterium tuberculosis Exploits the TLR2 Signaling in
Macrophages Eliciting an Anti-Inflammatory Response by Producing IL-10
S. Mukhopadhyay, S. Nair, S.C. Mande, S.E. Hasnain
Hyderabad (India)
72.005
BCG Vaccine Reaction in Infants
S. Rafiee Tabatabaei , S. Mohebatti, H. Behbod
Tehran (Iran)
72.006
Chemokine Receptor-Mediated Delivery of Mycobacterial MPT51 Protein
Efficiently Induces Antigen Specific T-Cell Responses
M. Uchijima,T. Nagata, Y. Koide
Hamamatsu (Japan)
72.007
Mutation in Alkylhydroperoxidase D Gene Dramatically Decreases Persistence of
Mycobacterium bovis Bacillus Calmette-Guerin in Infected Macrophage
T. Naserpour Farivar, P. Johari, A. Borji
Zahedan (Iran)
72.008
Anti-PPD T-Cell Response in TB Patients is Modulated by Mycobacterium tuberculosis
Heat Shock Protein 60
S. Ghousunnissa, K. Nooruddin, A. Kaiser, S. Mukhopadhyay
Hyderabad (India)
72.009
Bioinformatics Study of Iron Dependent Transcriptional Regulator, IdeR, from
Mycobacteria
S. Ranjan, A. Ranjan
Hyderabad (India)
Final Program
72.001
193
Session 73
12:30–13:30
HIV/AIDS OPPORTUNISTIC INFECTIONS
73.001
Association Between Human Immunodeficiency Virus Infection and Cerebral
Malaria in Children Below 12 Years Attending Mulago Hospital, Uganda:
A Case-Control Study
P.D. Imani, J.K.Tumwine, P. Musoke, J. Byarugaba
Kampala (Uganda)
73.002
Hepatitis G Virus Infection in Patients Infected with the Human
Immunodeficiency Virus
A. Ramezani, M. Mohraz, R.Vahabpour, S. Jam, M. Banifazl, A. Eslamifar,
F. Mahboudi, A. Aghakhani, R. Edalat, S. Hekmat
Tehran (Iran)
73.003
Frequency of Mycobacterium tuberculosis Infection Among HIV/AIDS
Patients in Tehran, Iran
S. Jam, M. Mohraz, D. Sabzvari, M. Hajiabdolbaghi, H. Jabbari, B. Moradmand Badie
Tehran (Iran)
73.004
Protean Manifestations of Herpes (HSV) Infection in AIDS Cases
S. Nagpal,Y. Marfatia
Baroda (India)
73.005
Prevalence and Co-Existance of Diabetes with HIV and Hcv Infection in
Kermanshah-Iran
A. Janbakhsh, F. Mansouri, S.Vaziri, B. Sayyad, M. Afsharian, S.S. Meigouni
Kermanshah (Iran)
73.006
Unusual Cutaneous Infections in HIV
B. Mehta, M. Dhingra, S. Amladi, C. Nayak, S. Savant
Mumbai (India)
73.007
HCV Treatment with Pegylated Interferon and Ribavirin in Patients with
Haemophilia and HIV/HCV Coinfection: A Retrospective Review
J.T. Denholm, E.J.Wright, A. Street, J.J. Sasadeusz
Melbourne (Australia)
73.008
Continuing Evidence Supporting the Role of Early Kinetic Monitoring (RVR) in
Predicting SVR for HIV/HCV Coinfected Patients
A. Jackson, D. O'Shea , E. de Barra, G. Farrell, J.Thornhill, F. Mulcahy, C. Bergin
Dublin (Ireland)
73.009
Prevalence of High-Grade Anal Intraepithelial Neoplasia (AIN) in Anal Lesions
in HIV+ Men Who Have Sex with Men (MSM) from a Venezuelan Private
Medical Center
S.M. Dickson-Gonzalez, M. Uribe, R. Alfonzo, M. Correnti, M.E. Cavazza,
A.J. Rodriguez-Morales
Caracas (Venezuela)
1 9 4 Final Program
Session 73
12:30–13:30
Epidemiologic and Immunologic Characters of HIV/TB Co-infected Patients
F. Almasi
Paris (France)
73.011
Growth Retardation and Anemia Among HIV-Infected Children in South India:
Need for Targeted Nutritional Interventions
A. Shet, N. Rajagopalan, E. Rameshkumar, C. Dinakar, C.K. Indumathi, S. Muthayya,
A. Kurpad
Bangalore, Namakkal (India)
73.012
Spectrum of Clinical Presentation and Opportunistic Infections in HIV:
An Indian Scenario
B.C. Pruthvi, S.Vikram, S.K. Suman, B. Jayaprakash, N.R. Rau
Manipal (India)
73.013
Isolation of Cryptosporidium meleagridis in a HIV- Positive Female— the First Report
from Poland
M.Wesolowska, B. Szostakowska, B. Knysz, J. Gasiorowski, A. Gladysz
Gdynia,Wroclaw (Poland)
73.014
Evaluation of Cerebrospinal Fluid (CSF) in Patients with HIV/Syphilis Co-Infection
Followed at Institute of Infectology Emilio Ribas, Brazil
E.J. Boccardo, M. Eira, R.J. Costa Silva, I.M. Moreira,T.A. Matos
São Paulo (Brazil)
73.015
Use of Multicopy and Single Copy Genes for Detection of Pneumocystis jirovecii and
Subsequent Analysis of Genotypes of Indian Isolates
R. Gupta, B.R. Mirdha, R. Guleria, S.K. Kabra, S.K. Agarwal, A. Mohan, K. Luthra,
V.K. Iyer
New Delhi (India)
73.016
Hearing Loss in HIV Positive Patients
M. Ohki, O. Katoh, A.Yamauchi, S. Kishida,Y. Kumagai, H. Fukuoka, N.Tayama
Tokyo (Japan)
73.017
HIV-TB Coinfection:The South Australian Experience
M.M. Sehu, R. Stapledon, D. Shaw
Adelaide, South Australia, South Brisbane, Queensland (Australia)
73.018
Integration of Routine HIV Testing with TB Diagnosis Among Medical Inpatients
in Mulago Hospital, Uganda
V. Gwokyalya, D. Mwesigire, C. Nawavvu, J. Ssenkusu, A.S. Namale, R.Wanyenze,
M. Kamya
Kampala (Uganda)
Final Program
195
73.010

Session 51 1 4 1 Conference Hall 1–3 Sunday, June 22, 2008

Transcription

Similar documents